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Microbiology

The Host Inflammatory Response to a Xenograft Arterial Bypass in a Rabbit Model
Director: David T. Cheung, Ph.D. ^ , C ,
Cardiovascular disease is the leading cause of death in the United States. In a six year
period, 12.9 million people were diagnosed with coronary heart disease with 515,204
deaths. When non-invasive treatments are insufficient, coronary bypass surgery is
necessary. Many graft options are available but not all are suitable as coronary bypass
grafts.
This study was designed to evaluate the effect of the host inflammatory response toward
the Corograft xenograft conduit material implanted in the arterial circulation. The
rabbit model developed is useful for the evaluation of small-diameter biological grafts
when implanted into the abdominal aorta, and the inflammatory response could be
increased via hypercholesterolemia or decreased via anti-inflammatory drug treatments.
Normal diet rabbits survive the surgery, maintain patent grafts for up to 6 months which
are recolonized by host eells. Hypercholesterolemic rabbits had an elevated post
operative mortality and aneurysm formation was seen in several rabbits, which was
attributed to hypercholesterolemia. Macrophages are increased, and can secrete matrix
degrading enzymes, leading to an increased inflammatory response leading to observed
aneurysm formation.
These grafts elicit a chronic-type inflammatory response allowing this model to be used
to study the effect of anti-inflammatory drugs. Grafts from drug-treatment samples were
partially recolonized by host cells and no aneurysm development was seen in any of these
samples. Both Indomethacin and Etidronate reduced overall macrophage numbers
compared to saline controls while the humoral response was not reduced.
These data suggest that macrophages, as part of an inflammatory response, may play a
role in vascular graft failure, and anti-inflammatory treatments reduce the host response
toward the graft material. This indicates that anti-inflammatory treatments after bypass
grafting could be important in the long-term survival of grafts in the clinical setting.
These data could also lead to further modifications of the original graft material during
production, leading to a product with superior resistance to inflammatory degradation.
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The Road Not Taken
-Robert FrostTwo roads diverged in a yellow wood.

In leaves no step had trodden black.

And sorry I could not travel both

Oh, I kept the first for another day!

And still be one traveler, long I stood

Yet knowing how way leads on to way,

And looked down one as far as I could

I doubted if I should ever come back.

To where it bent in the undergrowth;
I shall be telling this with a sigh
Then took the other, as just as fair.

Somewhere ages and ages hence:

And having perhaps the better claim.

Two roads diverged in a wood, and I

Because it was grassy and wanted wear;

I took the one less traveled by.

Though the passing there

And that has made all the difference.

Had worn them really about the same.
And both that morning equally lay

xm

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Background
Cardiovascular and Coronary Heart Disease
Cardiovascular disease (CVD) has been the primary cause o f death in the United
States since 1900 and has killed more people than the next five causes of death combined
(cancer, chronic lower respiratory diseases, accidents, diabetes, influenza and
pneumonia)

Between 1988 and 1994, an estimated 62 million people in the United

States were diagnosed with some form of cardiovascular disease, and of these 12.9
million people were diagnosed with eoronary heart disease (CHD) with 515,204 deaths
attributed to CHD

This corresponds to an average total (direct and indirect) cost of

$21.7 billion per year for eoronary heart disease. In 2000 alone, interventions to treat
CHD ineluded 519,000 coronary artery bypass grafting (CABG) surgeries performed in
314,000 patients; 561,000 percutaneous transluminal coronary angioplasty (PTCA)
interventions in 547,000 patients; 456,000 stenting procedures; and 2,401,000 other
procedures which include valve replacements, open heart surgeries, paeemakers,
endarterectomies, defibrillators, and cardiac catheterizations ^
A variety of factors contribute to the development o f CVD, including but not
limited to; diet, health status, genetic predisposition, level of activity, smoking, and
obesity. If the condition is not advanced to the point of needing surgical intervention,
patients can be treated with medications, encouraged to quit smoking, exercise more, and
educated in ways to improve their diet and control diabetes. If medication, diet and
exercise are insuffieient in controlling the progression of the disease, then more
aggressive treatments are available. Depending on the severity o f the condition, catheterbased coronary revascularization therapies such as percutaneous transluminal coronary
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angioplasty, coronary arthrectomy, laser coronary angioplasty, and coronary stenting
have proven to be highly effective in a selected population, but restenosis has been a
common complication with these procedures
In cases where further intervention is necessary by-pass surgery (also CABG or
Coronary Artery Bypass Grafting) is performed. During coronary artery bypass grafting,
a blockage or stenosis within the coronary artery(s) is bypassed using an autologous
small-diameter arterial or venous conduit. This serves to immediately improve blood
flow to under-perfused areas of the heart, relieve angina, and prevent myocardial
infarction.

Coronary Graft Options: Advantages, Disadvantages and Limitations
Vascular grafts represent a significant percentage of all the medical device
implantations performed worldwide

and have clinical applications in peripheral

vascular surgery, arterio-venous shunt construction and coronary artery
revascularizations. The choice of conduit is important for the outcome of a coronary
artery bypass graft surgery (CABG), and graft patency is associated with an uneventful
post-operative recovery and long-term patient survival

The determination of patency is

based upon conduit type (arterial or venous) and the location o f the graft insertion (which
coronary artery) into the coronary circulation, but regardless of location and graft type, a
high average flow has be used as an indication o f a viable patent graft ^ (Table 1: Mean
Flow).
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Table 1: Flow readings were recorded during coronary artery bypass surgeries using a
Transonic Flow Probe. The normal flow readings shown are for 85% of all measured
cases, and normal flow is given for each graft type and position. Normal coronary flow
(left and right) is approximately 4% of the cardiac output, or about 225ml/min for a
5L/min cardiac output ^ and is split between the right and left coronary branches.
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Table 1: Mean Flow of Arterial and Venous Bypass Grafts

Mean Flow Readings through Grafts during Surgery*
Graft Location
Normal Flow
Questionable flow
Obstructed
LIMA to LAD
RIMA to RCA
SV G to R C A
S V G to DIAG
S V G to 0 M 1 /0 M 2
SV G to PD A
SV G to CX

> 27
>26
>29
>21
> 29
>24
>48

m l/m in
m l/m in
ml/min
m l/m in
m l/m in
m l/m in
m l/m in

27
26
29
21
29
24
48

to
to
to
to
to
to
to

5
5
5
5
5
5
5

ml/min
ml/min
ml/min
ml/min
ml/min
ml/min
ml/min

Flow le s s th a n
5 ml/min

*Adapted from Transonic Systems, 2002
The Left and/or Right Intemal Mammary Arteries are dissected from the chest wall and
direetly grafted to a coronary artery. Saphenous Vein Grafts are harvested from the leg,
reversed and grafted from the ascending aorta (proximal) to the coronary artery (distal).
LIMA - Left Intemal Mammary Artery, RIM A - Right Intemal Mammary Artery, SVG Saphenous Vein Graft, DIAG - Diagonal, OM - Oblique Marginal, PDA - Posterior
Descending Artery, CX - Circumflex Artery, LAD - Left Anterior Descending, RCA Right Coronary Artery
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Vascular grafts: Clinical and Experimental
The available graft options, either autologous or non-autologous, possess one or
more o f the charaeteristies described for an ‘ideal’ graft

These include

bioeompatibility, lack o f chemical reactivity, low thrombogenicity, porosity, cost,
sterility and no leaching of processing chemicals. The ideal physical characteristics for
grafts include: infection resistance, flexibility, resistance to kinking and compression,
stretch, size range, tensile and shear strength, resistance to arterial pressure, and
compliance. While several types of grafts are available, autologous grafts are the first
choice. Problems arise when patients return for a re-operation for failed grafts or have
pre-existing vascular disease

and no autologous conduits are available which is the case

for 15% of patients returning for a re-operation

In these cases, suitable autologous

conduits may not be available, and other options must be explored. These options will be
described in the following paragraphs.

Autologous Grafts
Autologous conduits can be either venous (Greater and lesser saphenous veins,
cephalic and basilic veins) ^ or arterial (Intemal thoracic, right gastroepiploic, inferior
epigastric, radial, splenic, gastroduodenal, left gastric, and intercostal)

These vessels

are harvested as part of the revascularization procedure and can be an additional source of
morbidity with associated risks and complications. The intemal thoracic artery (ITA,
also intemal mammary artery or IMA) and greater saphenous veins are the first and
second choices for small diameter conduits used in revascularizations

The other

choices are less commonly used.
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The ITA has a 90% patency at 10 years when grafted to the left anterior
descending artery (LAD) compared with a 40-50% patency for venous grafts

An

estimated 10-15% of all vein grafts occlude within the first year, after which the failure
rate is estimated at 1-2% for years 1-6 years, and 4% per year for years 6-10

O f these,

30% o f vein grafts require re-intervention within two years due to significant stenosis due
to intimal hyperplasia

Within 10 years, 30-40% of the re-vascularizations performed

using autologous conduits are occluded due to atherosclerosis or stenosis secondary to
atherosclerosis, and of the remaining 60-70% only half are firee of significant amounts of
stenosis
Intimal hyperplasia is the most common cause of graft failure when autologous
vein is used for peripheral or coronary bypass surgeries, accoimting for 30 to 50% of all
graft failures

, The majority o f vein grafts placed in the arterial circulation develop

intimal hyperplasia within 6 weeks of implantation, which has been attributed to vessel
wall ischemia and stress

These factors contribute to endothelial dysfunction, an

important early step in the development o f intimal hyperplasia ^'^4 8 ^o,2 i
atherosclerosis

Experimentally, autologous venous conduits have been shown to be

more susceptible to accelerated atherosclerosis and intimal thickening than arterial grafts
23

Non-Autologous Grafts
Synthetic Grafts: Commercially available synthetic grafts include
polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE, Teflon™), polyethylene
terephthalate (PET, Dacron™), and polyurethanes. Synthetic conduits are attractive due
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to their physical characteristics and lack of immunogenicity

Grafts with an intemal

diameter of 6mm or greater have worked well under clinical conditions

while

grafts with an intemal diameter of 6mm or less have met with a high failure rate due to
thrombosis, or thrombosis secondary to intimal hyperplasia
PTFE grafts have a satisfactory short-term performance but are susceptible to
infection and intimal hyperplasia

These conduits become re-endothelialized on the

pannus ingrowth fi'om the anastomosis while thrombus forms in the more central portions
of the grafts and can become occluded due to pannus sloughing or intimal hyperplasia at
the anastomic junction

PTFE patency rates in the coronary position vary from 59%

between 1 to 26 months, 64% at one year, and 14% at 45 months, but these grafts rarely
remain patent in the coronary position
ePTFE is not very hemocompatible/wettable and is not considered suitable for
applications needing a small diameter graft of 4mm or less

One patient is documented

in literature with a patent 4mm ePTFE aortocoronary graft at 12 years

This patient

had unsuitable greater saphenous veins and intemal mammary arteries.
Dacron grafts have been successful in the coronary position when used as short
interposition grafts in areas o f high flow (ascending aorta and proximal end of the
coronary artery)
Polyurethane grafts implanted into animals as peripheral grafts resist thrombosis
and showed a rapid cellular ingrowth with a reduced incidence of intimal hyperplasia at
the anastomosis

However, when 7 different brands of polyurethane grafts were used

in clinical applications (peripheral implantation or Arterio-venous (AV) fistulae for
hemodialysis access), these grafts had a high rate of thrombosis, were prone to infection
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and the patency in the femoro-popliteal position varied from 47-59% at 6 months, and as
AV fistulae from 73% at 6 months to 45-64% at 1 year

Aria™ grafts (Thoralon®

polyurethanurea with silicone) were implanted into 27 patients for compassionate use
between 1993-96, and at 1 year five patients had died of causes unrelated to the graft
while the remaining 22 patients were alive and asymptomatic

No polyurethane grafts

are currently approved for human use.
Biological Grafts: Detergent/enzymatically extracted grafts o f human or animal
origin

have met with some success in animal models

but are not generally

available for clinical implantation into humans. Fixed xenogenic grafts such as
dialdehyde-tanned bovine internal thoracic artery have been used, but this graft was
deemed unsuitable having a 16% patency rate at 10 months
Umbilical vein conduits (both cryopreserved and glutaradehyde-fixed) are
potentially an ideal non-autologous conduit source as they are easily obtained and are
able to withstand arterial pressure and stress due to their circumferential elasticity,
however they are potentially immunogenic, prone to intimal dissection, and only have a
50% short-term patency rate which limits their use

Umbilical vessels fixed in

glutaraldehyde have found clinical applications in lower limb revascularization but long
term patency is poor and they are susceptible to aneurysmatic degeneration
Greater saphenous vein (GSV) grafts are easily obtained (cryopreserved and
glutaraldehyde-fixed) but immunogenicity is a problem and the cryopreserved grafts have
a high failure rate due to a deteriorated intima. Patency data indicates these grafts should
be used with caution and only in cases where no autologous grafts are available

GSV

homografts (12 of 38) had a patency rate o f 31.5% at 1 year. Cryopreserved GSV (61

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

grafts in 28 patients) had a 65% patency rate at 2 weeks, while at 12 months none of the
13 grafts examined were normal. In another study, cryopreserved GSV patency at 7.5
months was 41% in 19 patients
Biodegradable Polymer Grafts: Biodegradable grafts

have been used under

experimental conditions with some success, but are not yet a viable clinical option.
These grafts consist of a biodegradable scaffold which, depending on the
composition/ratio o f the components, can be ‘programmed’ to degrade within a defined
period of time. The most common polymers used as scaffold material are poly L-lactic
acid (PLLA), polyglycolic acid (PGA), poly DL-lactic-co-glycolic acid (PLGA), and
poly-4-hydroxybutyrate (P4HB)

These grafts are usually seeded with cells in vitro

prior to implantation

General Conclusions on Graft Options
“An excellent substitute conduit for coronary bypass operations that can be taken
‘off the shelf is certainly the dream of every practicing cardiac surgeon”

Since 1942,

significant efforts have been made to develop alternative grafts for vascular applications
but have met with limited success

Graft options other than autologous conduits are

experimental, have unsatisfactory patency rates, or both. The major issues linked to
vascular graft failure include immediate and long-term patency, lack of complete reendothelialization, aneurysmic degeneration, and intimal hyperplasia. The available
information leads one to conclude that a satisfactory small-diameter blood vessel
replacement has not yet been found.
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Xenograft Developed at IHI (Corograft ”)
The Corograft™ conduits used in this study were obtained from Philogenesis
(Monrovia, CA), the company responsible for the commercial production and distribution
of the conduit material developed at IHI. The conduits used in this study are bovine
arterial grafts treated by the L-Hydro™ method to reduce antigenicity. The L-Hydro™
treatment for biological transplantable tissues (Patent pending) consists of two steps: the
first step combines a mild extraction of antigens without the use of detergents or digestive
enzymes and the masking of unextracted antigens by a polyglycol in conjunction with a
mild chemical oxidation under physical conditions that protect the extracellular
components (such as collagen and elastin), and as a second step the incorporation of a
common anti-inflammatory agent (equivalent to aspirin) and an anti-thrombotic agent
(equivalent to heparin). The conduits are then lyophilized prior to being gas-phase
sterilized (D-Hydro™).
These conduits have been implanted in a sheep model into both a peripheral
(carotid) and coronary position and compared to autologous venous conduits. When
implanted as a coronary bypass (ascending or descending aorta to LAD), Corograft™
conduits (less than 4mm ID and more than 10cm in length) showed excellent patency
rates at five or more months. When examined histologically, the implants were readily re
colonized by host cells in vivo and showed a complete endothelial-like covering of the
lumen with smooth muscle cells in the media of the arterial graft wall. When implanted
in the carotid artery of sheep, complete endothelialization occurred within 3 months postoperatively. No evidence of thrombosis, stenosis or aneurysm was seen in these studies.
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These conduits have several advantages including biocompatibility, off-the-shelf
availability, absence o f toxic cross-linking agents (glutaraldehyde or formaldehyde),
room temperature storage, simplified shipping, and no co-morbidity associated with
autologous vessel harvest. The graft material is easy to handle and use, can be tailored to
the particular application, and takes a suture well without tearing. These technologies
have been applied to valves with promising results

Although the Corograft^” implant

studies in sheep have shown promising results, the exact role the anti-inflammatory
strategy in the treatment o f the graft has not been established. The optimum dosage for
the anti-inflammatory agents used has also not been determined.
In order to study the role of the host inflammatory response to a xenograft arterial
bypass, three questions needed to be answered: 1) Which animal models and graft
materials are most appropriate, so that the graft remains patent for an extended period of
time? 2) If the original hypothesis that inflammation contributes significantly to the
failure of a xenograft implants is true, can we the chose a model to study the role of
increased inflammation on the implant? 3) Can we find alternate ways of decreasing the
inflammatory response toward the graft? Three sets of experiments were designed to
answer of these questions: 1) a rabbit model with a xenograft implanted in the abdominal
aorta was studied, 2) inflammation was enhanced by diet-indueed hypercholesterolemia
to see if this accelerated the failure of the graft, and 3) inflammation was suppressed by
the administration of anti-inflammatory agents to see if graft durability eould be
improved. Eaeh o f these experiments will be addressed in separate chapters.

II
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Chapter I
Development of the Animal model
Introduction
Choice of Animal Model
Many issues must be taken into consideration vi^hen choosing an animal model for
vascular graft testing. These may include length and size of the graft which will dictate
the anatomical locations available for implantation. Composition and size of the graft
(e.g. biological vs. synthetic) may also play an important role in site selection (e.g. aorta
vs. femoral vs. coronary) as well as animal model used (large vs. small). The coagulation
and fibrinolytic characteristics of the individual models must be considered and
compared to the human system. Other issues may include availability, human perception
(e.g. using a dog model vs. sheep model), housing and nutritional requirements, body
size, etc. Animal models used in the past to evaluate vascular grafts include calf,
primate, pig, sheep, dog, rabbit, rat, and mouse, each with its’ own advantages and
disadvantages.
Another important consideration in evaluating models for vascular grafts is the
dynamics o f re-endothelialization. The majority o f the animal models will spontaneously
re-endothelialize (with exception of the dog), which is in direct contrast with the human
system

Re-endothelization in humans is usually limited to a distance of ~ 1cm from

the anastomosis and appears to correspond to the maximal distance of pannus
ingrowth/anastomotic hyperplasia.
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Rabbit Model
The rabbit model has been used extensively for the in vivo evaluation of small
bore (less than 6mm) vascular grafts
are similar to that of bumans
rabbit arteries

The tbrombogenic properties of rabbit blood

as are the tbromboplastic and fibrinolytic properties of

making the rabbit an ideal model for experimental small-diameter

vascular graft studies. Furthermore, the ease of animal handling, size and cost
effectiveness make this model attractive. Their low cost makes them economical in
studies requiring a larger sample size and their small size allows for easy handling and
boarding. The main disadvantage is their smaller size, necessitating magnification during
surgery and the use o f microsurgical techniques and instruments.

Surgical Model - Location of Implantation
The location o f graft implantation depends on the graft to be tested, size o f the
graft, and other issues such as arterial vs. venous conditions (high vs. low flow).
Common sites of arterial implantation in the various animal models include the carotid
arteries, as a coronary bypass, the thoracic aorta, the abdominal aorta, as well as the iliac
and femoral arteries. In a rabbit model, several sites are have been used for for graft
implantation studies; the carotid artery, the iliac artery, the femoral artery, thoracic aorta,
and the abdominal aorta.
Many studies have used the rabbit model to evaluate small diameter grafts, but the
grafts were placed into the carotid position. The carotid position in rabbits has been used
in the past to evaluate the behavior of autologous vein grafts under both normal and
atherosclerotic conditions

However, this position is not suitable for the
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evaluation o f a 2-3mm vascular graft due to the size mismatch between the carotid artery
and the graft. In the rabbit the thoracic and abdominal aortae fall into this size category.
Therefore, the abdominal aorta was chosen in this study because the graft would
be under arterial pressure, the diameter of the aorta more closely matches the diameter of
a human coronary artery, and the flow is similar to bypass graft flow conditions. The site
is also easy to access (compare to the thoracic aorta), the surgery is less invasive than the
thoracic position, does not require active ventilation, and several studies had been done
implanting vascular grafts into this position 46.48,49,55,56^

course of the study,

modifications in the surgical protocol were made to increase operative and post-operative
survival as well as decreasing the incidence of post-operative paralysis, a common
occurrence in surgery on the abdominal aorta.

Specific Aim: To develop an animal model in which the Corograft^" conduit can be
implanted, remain patent long-term, and allow for the study of the host
inflammatory response toward the graft material under varied conditions.

Rationale
With an increasing number of bypass grafts and re-operations being performed
each year, there is an urgent need to develop an alternative to the currently available
coronary graft options. Autologous conduits as well as synthetic and biological options
explored to this point have all fallen short of the optimal outcome, a disease-free, fullyintegrated conduit. The key role of inflammation in the failure of both autologous and
non-autologous options is finally being acknowledged, though much work still needs to
14
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be done to address this issue. To these ends, a model was developed in which the graft
material could be implanted and the inflammatory response could be increased or
decreased as desired.

Experimental design
The pilot group consisted of 11 rabbits in which the surgical protocol was
optimized by the addition o f an end-to-end anastomosis, systemic hypothermia and
supplemented Lactated Ringers solution. This protocol was then used to implant the graft
into an additional 54 rabbits in two experimental groups, 26 rabbits in diet group and 28
in the drug groups. In the diet group, the graft performance was evaluated out to 6
months and to 2 months in the drug groups.
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Materials and Methods
Animal Source and Care
Female New Zealand White rabbits (weighing ~3-4kg) were purchased from
Westem Oregon Rabbit Company (Philomath, OR, USA) and allowed to acclimate for at
least 7-14 days before initiating any procedures. Rabbits had access to normal rabbit
chow and water ad libitum through out the duration of the study. Average room
temperature was 63°F (17-18°C), with a 12hr day/night cycle and 10-12 air changes/hr.
All animals appeared clinically normal throughout the quarantine period and no other
pathogen testing was done.
All animals were cared for in accordance with the ‘‘Principles o f Laboratory
Animal Care ” formulated by the National Society of Medical Research and the “Guide
fo r the Care and Use o f Laboratory Animals ” prepared by the Institute of Animal
Resources, National Research council, and published by the National Academy Press,
revised 1996. The use of the animals for this project was reviewed and approved by the
Institutional Animal Care and Use Committee (lACUC) of The University of Montana.
The submitted protocol also included criteria for analgesia and euthanasia.

Preoperative Preparation
Rabbits were sedated with an intramuscular dose of ketamine (50mg/kg), the
abdominal region shaved, and the rabbit placed in a dorsal recumbent position on a
heating pad (heating pad was off during the hypothermic phase of the surgery).
Anesthesia was induced and maintained with 1.5-2% Isoflurane/Oxygen mixture
administered via a ventilator/anesthesia delivery system (North American Drager,
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Telford, PA, USA or Isotec 4, Surgivet/Anesco Veterinary Surgical Products, Waukesha,
WI, USA), and the level of isoflurane was adjusted as needed to keep the animal
sufficiently anesthetized, as evaluated by ear pinch or any evidence of discomfort. The
chest cavity was not opened allowing for passive, spontaneous ventilation by the animal
The core temperature was monitored with a rectal temperature probe and
electrocardiographic leads were attached so the heart rate could be monitored. Icepacks
were placed around and between the hind-legs and along the lower flanks. An intra
venous cannula (22 gauge) was introduced into the marginal ear vein and cold (4°C)
supplemented Lactated Ringer’s Solution was given initiating the hypothermic phase of
the surgery. The supplemented Lactated Ringer’s solution contained per liter: 20ml
sodium bicarbonate (84mg/ml and 50mEq/50ml, American Pharmaceutical Partners, Inc.
Los Angeles, CA, USA), 50ml of 20% mannitol solution and 0.5ml dexamethasone
sodium phosphate (4mg/ml, American Regent Laboratories, Shirley, NY, USA).

Surgical Protocol
After sterile draping, a midline laparotomy was performed. The skin was
retracted with traction sutures and the intestines were displaced to the right side and
wrapped in laparotomy sponges moistened with cold sterile saline. Isolation of the
abdominal aorta from the surrounding tissues from below the left renal artery to the iliac
bifurcation was performed meticulously to avoid accidental injury to the inferior vena
cava and its branches. Care was taken to identify all aortic branches along the entire
circumference. If feasible, anastomotic sites were planned to avoid cutting of the large
dorsal aortic branches. Once all dissection was completed, one ml of heparin was
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administered i.v. (1000 USP units/ml, American Pharmaceutical Partners, Inc., Los
Angeles, CA, USA) and if necessary, further cooling of the animal was achieved by using
sterile saline slush applied directly into the abdominal cavity and to the laparotomy
sponge covering the intestines.
When the rectal temperature of the animal reached 34.5°C, the ice packs and the
saline slush were removed as the temperature continued to drop without additional
cooling. The cold supplemented Lactated Ringer’s solution was exchanged for warm
(37°C). Also, warm packs were placed next to the rabbit under the sterile draping and the
heating pad under the rabbit was switched on to start the re-warming phase of the
procedure initiating the re-warming period of the surgery.
Dorsal aortic branches within the previously prepared aortic segment were clipped
and cut. The aorta was occluded proximally and distally with micro-surgical vascular
clamps (MORIA 200/A, Angled, 30mm. Fine Science Tools, Inc. Foster City, CA, USA)
placed below the left renal artery and above the inferior mesenteric artery. And keeping
in mind the elastic recoil of the vessel, the aorta was cut approximately 1cm from each
clamp to avoid space issues.
All animals had a Corograft™ (~3-4mm ID x ~4cm minimum) previously re
hydrated in heparinized saline, implanted into the infrarenal abdominal aorta. An end-toend anastomosis (distal then proximal) was performed with a continuous single 8/0
Prolene suture (Polypropylene, Ethicon, Inc., Somerville, NJ, USA). Before tying the
suture for the proximal anastomosis, the distal vascular clamp was removed to flush air
from the graft by filling the graft with blood to avoid an air embolism. After tying the
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suture, the proximal vascular clamp was removed and additional 8/0 Prolene suture used
(as needed) to control anastomotic or graft bleeding.
The intestines were returned to the abdominal cavity and repeatedly lavaged with
warm sterile saline to achieve appropriate re-warming of the animal. When the rectal
temperature of the rabbit reached 36.5°C to 37.5°C, the saline was removed and the
laparotomy closed in two layers with 3/0 Vicryl (Polygalactin 910, Ethicon, Inc.,
Somerville, NJ, USA). The supplemented Lactated Ringer’s solution was discontinued,
with a total amount of 100-150ml having been administered for both the cold and warm
solutions. When the animal was re-warmed to physiological temperature (101-104°F/3840°C) and movement was seen in the hind-limbs, the animal was returned to its’ cage.
Rabbits received 0.2ml flunixin meglumine (50mg/ml, Equileve®, Phoenix
Scientific, Inc., St. Joseph, MO, USA) i.m. as an analgesic immediately after surgery, and
0.2ml i.m. flunixin meglumine BID for 4 days post-operatively. All rabbits were
monitored for neurologic or ischemic complications of the hind limbs throughout the
study. No antibiotic prophylaxis, platelet aggregation inhibitors nor anticoagulants were
used postoperatively.
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Results
Pilot group
The pilot group consisted of 11 rabbits in which the surgical, anesthesia, and
hypothermia techniques were optimized. Initially, the graft material was implanted into
the carotid position in 3 rabbits, but this was discontinued. All subsequent rabbits had the
conduit implanted into the abdominal position. The graft was implanted into the
abdominal position without hypothermia in four rabbits, all of which died during surgery.
One died due to excessive cross-clamp time, the other due to anesthetic complications,
the remaining two rabbits due to unknown causes. Two rabbits underwent surgery with
systemic hypothermia, but died during the procedure. Of the two that survived the
surgery, one died the following day and the other was euthanized at 22 days.
Incorporation of systemic hypothermia, modified Lactated Ringers solution and
short cross-clamp time resulted in greater graft patency. All grafts implanted into normal
rabbits were patent at surgery (13 of 13), and ten were patent at sacrifice at 2 (n=3), 4
(n=4) and 6 months (n=3). Of the additional three, one rabbit died at 5-i- months due to
intestinal ischemia and two rabbits were euthanized due to post-operative complications
and were excluded from the study. For the cholesterol-diet rabbits all 13 grafts were
patent at surgery, and with the exception of the 2 month sample, the grafts harvested from
the cholesterol-diet rabbits were post-mortem samples and patency could not be assessed.
In the drug treatment groups, 28 of 28 grafts were patent at surgery and 15 at sacrifice.
The additional 13 rabbits died or were sacrificed due to peri-operative or post-operative
complications unrelated to graft patency. O f these, 2 rabbits developed paraplegia.
These results are summarized in table 2.
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Table 2: Except for three rabbits in the pilot group which had the graft implanted in the
carotid position, all other rabbits had the 3-4mm diameter x 4cm Corograft™ xenograft
conduit implanted into the abdominal aorta distal to the kidneys but proximal to the iliac
biftircation. The Pilot Group includes rabbits used to develop the surgical model in
which the operative variables (hypothermic and cross-clamp time) were optimized. The
Normal Diet group includes all rabbits fed a normal rabbit chow, while the Cholesterol
Diet group includes all rabbits fed commercially available rabbit chow supplemented
with 1% cholesterol. The Drug Treated group includes rabbits in which saline,
Indomethacin or Etidronate were administered suhcutaneously during the duration of the
study. The total number of rabbits implanted with a graft in each group are listed in the #
Operated column. The total number of rabbits included in each group are listed in the #
Valid column, and represent animals sacrificed when scheduled. The remainder of the
animals were excluded due to death, operative or post-operative complications unrelated
to the graft.
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Table 2: Valid Animals

Group
Pilot Study
Normal Diet
Cholesterol Diet
Drug Treated
Total

# Operated
11
13
13
28
65

# Valid
# Excluded
NA
NA
3
10
12
1
13
15
28
26
NA - Not Applica ?le
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Discussion
The implantation of small-diameter vaseular grafts, either of human or synthetie
origin, is performed daily in current medical practice and the number of vascular grafts
implanted each year numbers over one million throughout the world. In the USA alone,
571,000 coronary artery bypass grafts were performed in 1999

Autologous arteries

and veins still represent the best treatment options, however pre-existing vascular
diseases or previous cardiovascular procedures emphasize the need for a safe, durable
and long-term altemative graft of an acceptable diameter.

Rabbit Model
This project was started due to an observation that the Corograft'^'^ conduit had not
been tested in a disease model, and that the long-term outeome of this graft under
eonditions of atherosclerosis would provide valuable information. This study would have
been prohibitively expensive in the sheep model used at the time to evaluate these grafts
in vivo. After reviewing the available literature the rabbit was chosen as a model due to
the amount of information in the literature using this model to evaluate small diameter
grafts (less than 6mm) and that inflammation could be increased or decreased in order to
further evaluated the role of inflammation on the host response toward the Corograft™ in
later portions of this study.

Abdominal Aorta
Initially, the graft material was implanted into the carotid position, but this was
discontinued for several reasons. There was a large size mismatch between the carotid
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artery (~l-2mm) and the graft material available at the time (3-4mm). The carotid
position was difficult to access due to limited space, and close proximity of the jugular
vein made it difficult to isolate the carotid without damage to the vein. Also, there was
no way to monitor the patency of the graft material during the long term study. This
approach was discontinued and the alternate implantation site of the abdominal aorta used
instead.
The abdominal aorta was chosen as it approximates the size and arterial
conditions of a human coronary artery (superior to implantation into the carotid position
of rabbits). The blood flow through the abdominal aorta proximal to the iliac bifurcation
for a rabbit is 65.1 ± 3.2ml/min

compared to ~225ml/min (split between the left and

right coronary arteries) through the coronary circulation in humans ^ This flow falls into
the normal flow range of a coronary graft from either an internal thoracic or the
ascending aorta to any coronary artery branch

An additional advantage of this model

is that if the graft occludes post-operatively, hind-limb paralysis results and serves as an
indicator of patency throughout the study. This is a separate issue from spinal chord
ischemia which can occur as a complication associated with surgery involving the
thoracic and abdominal aorta, and also results in hind-limb paralysis in the rabbit model
57

Hypothermia and Cross-Clamp Time
The basic surgical protocol put forth by Nordestgaard et al.

was explored as a

model of graft implantation into the abdominal aorta of rabbits. Initially, several cases of
postoperative paraplegia in rabbits implanted with a Corograft™ conduit led us to explore
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reasons for these complications and a literature review indicated that normothermic
ischemic injury of the spinal chord had been previously shown to result in paraplegia
4 8 , 57,60

application of controlled mild systemic hypothermia (32-34°C) to

this surgical model. Mild hypothermia offers significant protection from ischemic spinal
chord injury resulting in increased recovery of motor function

and reduces

metabolic demands during the ischemic period
However hypothermia alone might be insufficient to avoid paraplegia when the
cross-clamp time was in excess of 20 minutes

For this reason the supplemented

Lactated Ringers solution was incorporated into the methodology. This was based in part
on a study by Ueno et.al.

in which they occluded the abdominal aorta of rabbits for 45

minutes and also infused Lactated Ringers solution alone or containing
methylprednisolone (MP), MP+Mannitol, or MP+mannitol+vitamins E and C, and found
no incidence of paraplegia in the group in which the complete solution was administered.
The Lactated Ringers solution used in this study was supplemented with sodium
bicarbonate, mannitol and dexamethasone sodium phosphate in an effort to further reduce
the incidence of paralysis due to spinal ischemia. This solution is similar to cardioplegia
formulations used during bypass surgery to protect the heart from ischemic damage and
would control metabolic acidosis (sodium bicarbonate), ischemic cellular swelling
(mannitol) and ischemia-reperfusion injury induced inflammation (dexamethasone).
The pilot group indicated that a cross-clamp time in excess of 30 minutes under
normothermic or mild hypothermic conditions contributed to a high rate of postoperative
paralysis in rabbits regardless o f graft patency. This observation was supported by the
study of Tolwani et.al.

where mild hypothermia and a mean cross-clamp time of 30
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minutes or less resulted in a 3% incidence of paraplegia, while without hypothermia the
incidence of paraplegia was 100%. This observation is also supported by Nordestgaards’
study where grafted rabbits had a high incidence of paralysis which could possibly be
attributed to their cross-clamp time. Their cross-clamp time varied from 20-50 minutes
under normothermic conditions and of 42 rabbits implanted with 2 and 3mm grafts, 18
developed paralysis during their study (42%).

Anastomosis
An end-to-side type o f anastomosis was initially performed which would simulate
grafting in humans bypassing an occlusion or stenosis in a coronary artery, with the
intention of sparing the spinal aortic branches from the abdominal aorta by ligating the
aorta between the anastomoses. Due to the technical performance of an end-to-side
anastomosis, a longer cross-clamping time and the possibility of anastomotic occlusion
by thrombus extension from the point of the tied native aorta, this approach was
discontinued. Instead, an end-to-end anastomosis was performed and every possible
effort was made to position the graft to avoid the clipping and cutting of large spinal
branches. A continuous suture pattem was chosen over an interrupted pattem in order to
minimize the cross-clamp time. An interrupted suture pattem is more commonly used
with smaller grafts under conditions where there is a possibility of producing a stenosis at
the anastomosis.
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Graft Length
The general criteria used by cardiac surgeons to evaluate an experimental vascular
graft for possible use as a coronary bypass in bumans are: 4mm diameter by 4cm length
with at least 4 months patency (Personal Communication, Dr. C. M. G. Duran). When
testing grafts in a rabbit model many published studies implanted grafts of ~ 1cm which
appears insufficient to adequately evaluate re-endotbelialization, which in bumans can
reach 1cm at each anastomosis due to pannus ingrowth. For this reason the graft length
implanted in this study was 3-4mm in diameter by ~4em in length in which patency was
confirmed out to 6 months.

Graft Performance: Corograft™ vs. Other Graft Options
O f the 58 rabbits implanted with a graft in the abdominal position, all grafts were
patent at surgery, giving a 100% immediate patency. Of the 26 valid animals (normal
diet n=l 1, cholesterol diet n=l, drug groups n=15), one possible case of thrombosis (Smo
death) gives a patency rate of 96%. Six rabbits of 58 developed paraplegia during this
study in the immediate post-operative period, giving a paraplegia rate of 10.3%. The
grafts were examined in all cases of post-operative paralysis, and none of the grafts were
thrombosed, suggesting that ischemic injury to the spinal chord might be the cause.
Patency could not be assessed due to post-mortem clotting for grafts removed from
rabbits found dead, but one death at 5 months due to intestinal ischemia might have been
due to thrombosis.
By comparison, Nordestgaard et.al.

implanted polytetrafluoroethylene eonduits

(2 or 3mm by 1cm) into the abdominal position of rabbits with a pateney rate of 24% for
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2mm grafts and 72% for 3mm grafts. Of the 17 rabbits with 2mm grafts, 12 were killed
or died within the first 7 days due to graft thrombosis, while 4 of the 5 survivors had
patent grafts at the end o f 3 months. Of the 25 rabbits they grafted with 3mm grafts, 19
grafts were patent at 1 week and 18 were patent at 3 months. Lee et.al. implanted 3mm x
35mm PFTE grafts into the abdominal aorta

under normothermic conditions. The

grafts were harvested at 7 and 42 days (5 each). They had no instances of thrombosis in
their study and no cross-clamp information was given.
The patency of PTFE (2mm x 15mm) in the carotid position of rabbits is excellent
at 2 weeks (89%), after which patency declines to 86% atl6 weeks, and -68% at 32
weeks compared to 100% patency for autologous grafts

Sparks et.al. implanted PTFE

grafts (2mm x 10mm) into the carotid position and evaluated patency at 7,14 and 21 days
(each n=5). Patency was 40% at 7 and 14 days with a patency of 20 % at 21 days
When PTFE or poljairethane grafts (1.5mm x 10mm) grafts were implanted into the
carotid position of rabbits by van der Lei et.al, no improvements in patency or
thrombosis resistance were seen

All polyurethane and PTFE grafts (each 4 of 4) were

patent at 1 hour, 2 of 4 were patent at 1 day, 1 of 4 at 1 week, while none were patent at
2, 3 and 6 weeks (each 6 o f 6). By comparison, all arterial autografts were patent to 2
weeks (not done at 3 and 6 weeks).
The differences in patency seen in these published studies could be attributed to
among other things surgical technique, but they serve to illustrate that the patency o f nonautologous small diameter grafts in the rabbit model is less than optimal. However, a
true assessment o f patency for these studies may be difficult to determine as only
successfully grafted animals may have been included in the published study. By
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comparison, the graft used in this study shows excellent patency and thrombosis
resistance, indicating that performance of this graft material is superior to previously
published studies where non-autologous grafts were implanted into the circulation of
rabbits.

Conclusions
Hypothermia in conjunction with the supplemented Lactated Ringers solution and
strictly observing a cross-clamp time of 30 minutes or less effectively reduced the
incidence of post-operative paraplegia in this study and contributed to the success of this
model

In addition, the surgical protocol is straight forward in its’ approach and gives

excellent results allowing for a greater percentage of valid animals, allowing for
refinement of the study approach and a reduction in the total number of animals needed
for a given study. When compared to similar studies in which a vascular graft was
implanted into the abdominal aorta or carotid artery position o f rabbits, the graft
implanted in this study had a 100% immediate patency rate in all study groups using a 34mm diameter graft with a 4cm length. The longer term patency and thrombosis
resistance of the Corograft™ is excellent, and exceeds published studies. However, in all
cases one must remember the rabbit is an animal model and that any findings must
eventually be verified in humans.
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Chapter II
The effect of an increased inflammatory response on graft survival

Introduction
Inflammation
Within several minutes of injury, the vessels in the area of injury vasodialate (heat
and redness) and become permeable, leaking fluid (edema) and leukocytes into the
injured tissue. This leads to the activation of the clotting, kinin, and fibrinolytic cascades.
Within several hours, neutrophils bind to the activated endothelium, extravasate into the
surrounding tissues, and actively phagocytize invading organisms and release other
inflammatory mediators, including M IP-la and -lb (Macrophage Inflammatory Protein),
which are responsible for attracting monocyte/macrophages into the area. Once present
the macrophages are also responsible for phagocytosis and the release of further
inflammatory mediators affecting coagulation, vascular permeability, and leucocyte
chemotaxis. Eventually the offending stimulus is phagocytized or removed and the
inflammatory response resolves. If the stimulus is not removed, the inflammatory
response may proceed into a chronic inflammatory reaction.
Chronic inflammation can follow acute inflammation or can develop
independently. Chronic inflammation may be a result of persistence of an infectious
microorganism (e.g. tuberculosis), the presence of foreign bodies (e.g. surgical implants)
or insoluble particles (e.g. silicosis), a persistent hypersensitive state (e.g. non-infectiveallergic contact dermatitis, autoimmune-rheumatoid arthritis), or due to an unknown
cause (e.g. Crohn’s disease) V Chronic inflammation is characterized by the presence of
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an inflammatory infiltrate (macrophages, lymphocytes and plasma cells, not usually
neutrophils), the formation of granulation tissue, fibrosis, and abnormal tissue
remodeling. The presence of macrophage giant cells, generated by the fusion of activated
macrophages, is indicative of an on-going chronic inflammatory reaction, and the type of
giant cell present can serve as a preliminary indicator of the type of offending stimulus.

Modes of Graft Failure
Implanted grafts are susceptible to failure via several mechanisms including
thrombosis, intimal hyperplasia, atherosclerosis, and aneurysm. The primary cause of
graft failure is thrombosis

Thrombosis can also occur secondary to intimal

hyperplasia and atherosclerosis as both are responsible for grafts stenosis which can
result in thrombosis via the reduction of flow

Thrombosis can also be a result of

atherosclerotic plaque rupture, as the lipid core of an advanced plaque contains a large
amount o f tissue factor that can initiate the coagulation cascade leading to thrombus
formation

Grafts can also fail by aneurysmatic degeneration

Intimal Hyperplasia
First described in 1906 by Carrel and Guthrie

intimal hyperplasia can develop

as a result o f mechanical, chemical or immunological injury to a vessel or when vein
grafts or prosthetic grafts are used ^ in clinical applications. Intimal hyperplasia is
characterized by neointimal thickenings composed of smooth muscle cells and
extracellular matrix which develop between the intemal elastic lamina and endothelium
(artery) or the endothelium and medial smooth muscle layer (vein). This is accomplished
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by the proliferation of resident vascular smooth muscle cells and may also involve the
migration of cells from surrounding tissue
While intimal hyperplasia is typically addressed as a pathological manifestation,
derangement of the normal healing response or as a response to an insult, it does occur
under normal conditions. It is responsible for the closure of the ductus arteriosus, the
arterio-venous shunt bypassing the fetal lungs during gestation, allowing normal
circulation and oxygenation of blood post-natally. It also occurs as a part of the normal
aging process and is seen as diffuse thickenings in the vasculature or at sites of
turbulence in the flow of blood at points where vessels branch (often referred to as
adaptive intimal thickenings).
Intimal hyperplasia appears to be linked to an inflammatory response as an
infiltration of mononuclear cells and T cells is a common finding. Cytokines from these
inflammatory cells may be responsible for initiating and supporting the proliferation and
migration of smooth muscle cells and the deposition of extracellular matrix. Research
has shown a strong correlation between the severity of the inflammatory response and the
ultimate severity of the hyperplasia, and reducing the inflammatory response like-wise
reduces intimal hyperplasia

Intimal hyperplasia may also play a role in the

development o f atherosclerosis
development of intimal hyperplasia

while hypercholesterolemia increases the
This process also contributes to the failure of

vascularized organ transplants and venous conduits used as bypass grafts
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Atherosclerosis
Atherosclerosis is primarily a disease of the large arteries and is the most
significant cause o f heart disease and strokes in westernized societies, accounting for
50% of all deaths

Risk factors associated with the development of atherosclerosis

include high levels of lipoproteins, genetic predisposition, sedentary life-style, obesity,
and smoking

This condition is characterized by the progressive accumulation of

lipid-laden macrophage-derived foam cells in the arterial wall, proliferation of smooth
muscle cells and foam cells, and the abnormal deposition of extracellular matrix. The
apoptosis o f foam cells releases the intracellular oxidized lipids into the surrounding
tissue that ultimately results in the formation of a necrotic lipid pool. These
atherosclerotic plaques in latter stages of the disease can encroach on the lumen of the
vessel causing a progressive stenosis. Both the rupture of a plaque releasing the necrotic
lipid core or the development of an advanced stenosis can lead to thrombosis of the
affected vessel. Atherosclerosis also affects vascular grafts (both artery and vein) and
can lead to graft failure directly (by the rupture of an advanced lesion resulting in
thrombosis) or indirectly (due to plaque formation causing a stenosis which reduces flow,
leading to thrombosis).
Macrophages play an important role in the development and progression of
atherosclerosis

’ ’ which can also be considered a chronic inflammatory response

‘ .

The lesions produced during the evolution o f atherosclerosis are dominated by
macrophages, and the severity of the disease appears to be linked to the prominence of
these cells. Activated T cells are also a significant component of atherosclerotic lesions,
and the presence o f T cells and macrophages suggests that a cell-mediated inflammatory
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response may play a role in atherosclerosis, with the macrophages functioning as antigen
presenting cells for T cells

Using a rat model of diet-induced atherosclerosis, T cell

infiltration was most significant within two weeks of initiating the hypercholesterolemic
diet, making up 60%, 29% and 34% of the infiltrating cells in lesions of the superior
thoracic, inferior thoracic and abdominal aorta, respectively

The secretory products of

macrophages and T cells have been implicated in the cellular responses that occur
throughout lesion formation

For example. Interferon P from activated T cells causes

smooth muscle cell apoptosis, inhibits collagen synthesis by smooth muscle cells, and
increases MMP release from foam cells, all which contribute to a reduction in the amount
of extracellular matrix and increased matrix degradation seen in atherosclerosis ^

Aneurysms
Aneurysm development has also been characterized as a chronic-type
inflammatory response

Four major factors have been implicated in the formation of

an aneurysmatic lesion: degradation of aortic wall tissue, inflammation and immune
response, wall stress, and predisposing genetic factors

however the initiating stimulus

for aneurysm formation is yet unclear. The formation of an aneurysm

is

characterized by dilation o f the affected vessel, remodeling of the vessel wall with
destruction o f elastin and abnormal deposition of collagen, and an extensive chronic
inflammatory infiltrate of macrophages and T cells

with associated elevated

production of matrix metalloproteases (MMPs)
The inflammatory infiltrate is thought to play a causative role in aneurysm
formation by stimulating the secretion o f MMPs and by releasing cytokines that induce
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the production of MMPs by activated in situ mesenchymal cells and phagocytic cells
The dilation is often attributed to the loss o f elastic tissue due to breakdown of this
component by matrix metalloproteases (MMPs) which are increased in human aneurysm
tissue

and animal models of aneurysm

Models of aneurysm formation have

shown that attenuating the inflammatory response inhibits further dilation while
increasing inflammation augments the development

Elevated plasma levels o f MMPs

are also seen in patients with abdominal aortic aneurysms and appear to correlate with
elevated tissue levels o f MMP in affected tissue

The Role of Inflammation in Vascular Diseases
Inflammation has been linked to the development of vascular conditions such as
intimal hyperplasia

atherosclerosis

and aneurysm

In these conditions there

is a response involving resident and inflammatory cells, matrix metalloproteases (MMPs)
and the extracellular matrix, resulting in abnormal matrix remodeling with thirming
(aneurysm)

or excessive/abnormal deposition (atherosclerosis and intimal

hyperplasia)
Levels of inflammatory markers (especially C-reactive protein (CRP), but also
IL6 , TNFa and adhesion molecules) have been used as indicators of cardiovascular
disease and levels correlate well with the severity o f the disease and may also be
predictive of future events
Atherosclerosis

CRP level were elevated in Intimal Hyperplasia

Aneurysm

indicating an ongoing inflammatory response in

each of these conditions. CRP levels have also been linked to thrombosis
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Jabs et.al.

examined samples o f normal and diseased vessels as well as diseased

coronary bypass grafts for the presence o f CRP. Their results showed the presence of
CRP protein in 82% of diseased coronary arteries and in 100% of the diseased bypass
grafts. These observations implicate inflammation in the failure of grafts implanted into
the circulation.
Since intimal hyperplasia, atherosclerosis, aneurysm and thrombosis have been
linked to the failure of vascular grafts implanted into the circulation, and in each
condition an important marker o f inflammation is elevated, leading to the hypothesis that
inflammation plays a key role in vascular graft failure.

Models of Human Disease
Many animal models have been adapted to approximate human vascular disease
and have been used with great success (e.g. Atherosclerosis; diet-induced without injury
with injury for advanced lesion formation by balloon or catheter denuding
Aneurysm formation; CaCb application
Hyperplasia; Grafting

Injury

Elastase perfusion model

Intimal

However, one must always remember that they

are an artificially created condition that does not spontaneously/normally occur in the
particular model. Physical and physiological parameters of the model must be carefully
evaluated and compared to the human system they are to represent.

Increasing Inflammation via Hypercholesterolemia
Inflammation has been linked to the development of atherosclerosis

and

previous work with animal models has shown that inflammation and the development of
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atherosclerosis are linked

This is supported by observations that endothelial cells

become activated £ind express adhesion molecules which allow for the binding and
transmigration o f monocytes, and these areas of activated endothelial cells correspond to
areas of developing atheroma. Once in the vessel media, these macrophages differentiate
into foam cells and contribute to the development of a chronic-type inflammatory
response

leading to complex lesions involving endothelial cells, macrophages, T

cells, and smooth muscle cells. In atherosclerosis, macrophage-derived foam cells are
the main component of lesions and are involved in the development and progression of
the disease
Published studies suggest that the production of MMPs as well as MMP activity
are increased by atherosclerosis. In a study by Galis et.al.

foam cells isolated from

rabbit atheroma were shown to produce MMPs constitutively when compared to alveolar
macrophages isolated from the same animal. Both stimulated and unstimulated foam
cells synthesized and released MMPs in vitro while alveolar macrophages did not, and
stimulation caused the foam cells to release additional MMPs

Hypercholesterolemia

has been shown to cause the increased secretion of MMP-2 and -9 in the aortas of
cholesterol-fed rabbits

which has been associated with the formation of abdominal

aortic aneurysms. MMP-2 production and binding to the aortic matrix has been shown to
be increased in abdominal aneurysm formation in human samples
of MMP-9 have been associated with abdominal aortic aneurysms

and circulating levels
Also partially

digested fragments o f ECM have been shown to induce an inflammatory response by
calling in lymphocytes, monocytes and PMNs
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Atherosclerosis is considered the primary cause of aneurysm development in
humans as atherosclerotic changes were seen in aneurysm tissue, there was an association
between aneurysm diameter and adventitial inflammation, and hypercholesterolemia
plays an important role in monocyte/macrophage chemotaxis and activation

In

humans, injury to the media caused by atherosclerosis, hypertension, smoking, genetic
factors, etc. that damaged the elastic components of the vessel, in conjunction with
alterations in the elasticity of the aorta due to pulse pressure, were considered critical for
aneurysmal dilation

In a study by Freestone et.al.

both hypercholesterolemia and

adventitial inflammation both played a role in aneurysm development in rabbit vessels.

Specific Aim: To evaluate the role of increased inflammation via an atherogenic diet
on the xenogenic graft material.

Rationale
Previous studies have shown that feeding rabbits a diet supplemented with
cholesterol leads to the development o f atherosclerosis ^2-54,68-70
atherosclerosis in humans

Since hyperlipidemia has been linked to the accelerated

development of atherosclerosis in prosthetic and vein grafts
is considered an inflammatory disease

and atherosclerosis

it was hypothesized that by inducing

atherosclerosis via a hypercholesterolemic diet in the rabbit model described in the
previous section, the severity of inflammation could he increased towards the Corograft™
conduit and the effect of increased inflammation on the vascular graft could be assessed.

46

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Experimental Design
In this portion of the study, 26 rabbits were divided into two groups. Thirteen
rabbits were fed a commercially available rabbit chow and thirteen were fed rabbit chow
containing 1% cholesterol for 3 months prior to surgery. Blood samples were collected
on a weekly basis and the serum cholesterol levels analyzed. Rabbits fed a cholesterol
diet had serum cholesterol levels well above normal, while normal diet rabbits showed no
increase. After 3 months of the diet, grafts were implanted into the abdominal aorta and
the rabbits continued on the respective diets. The grafts were harvested at 2 ,4 and 6
months and analyzed by histology and immunohistology. Also, zymograms for MMP
activity and a Humoral ELISA were performed on surgery and sacrifice serum samples.
As atherosclerosis is considered an inflammatory disease, the presence of atherosclerotic
type lesions within the vasculature or the graft material would be used as an indicator of
increased inflammation. CRP levels were to be analyzed but proved to be prohibitively
expensive and were not done.

47

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Materials and Methods
Animal Source and Care
Female New Zealand White rabbits (Oryctolagus cuniculus) were obtained from
Western Oregon Rabbit Company (Philomath, OR, USA) and were allowed to acclimate
for at least 14 days before initiating any procedures. Rabbits were fed either normal
rabbit chow (Laboratory Rabbit Diet HP, #5326, Lab Diet, Richmond, ID, USA) or chow
with 1 % cholesterol added, and water ad libitum throughout the duration o f the study.
Average room temperature was 63°F (17-18°C), with a 12hr day/night cycle and 10-12
air changes/hr. All animals appeared clinically normal throughout the 14-day quarantine
period and no other pathogen testing was done. Venous blood samples were collected
weekly prior to surgery and monthly after surgery for serum cholesterol levels.

Preoperative Preparation
Rabbits were sedated with an intramuscular dose of ketamine (50mg/kg), the
abdominal region shaved, and the rabbit placed in a dorsal recumbent position on a
heating pad (heating pad was off during the hypothermic phase o f the surgery).
Anesthesia was induced and maintained with 1.5-2% Isoflurane/Oxygen mixture
administered via a ventilator/anesthesia delivery system (North American Drager,
Telford, PA, USA or Isotec 4, Surgivet/Anesco Veterinary Surgical Products, Waukesha,
WI, USA), and the level of isoflurane was adjusted as needed to keep the animal
sufficiently anesthetized, as evaluated by ear pinch or any evidence o f discomfort. The
chest cavity was not opened allowing for passive, spontaneous ventilation by the animal
The core temperature was monitored with a rectal temperature probe and
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electrocardiographic leads were attached so the heart rate could be monitored. Icepacks
were placed around and between the hind-legs and along the lower flanks. An intra
venous cannula (22 gauge) was introduced into the marginal ear vein and cold (4°C)
supplemented Lactated Ringer’s Solution was given initiating the hypothermic phase of
the surgery. The supplemented Lactated Ringer’s solution contained per liter: 20ml
sodium bicarbonate (84mg/ml and 50mEq/50ml, American Pharmaceutical Partners, Inc.
Los Angeles, CA, USA), 50ml of 20% mannitol solution and 0.5ml dexamethasone
sodium phosphate (4mg/ml, American Regent Laboratories, Shirley, NY, USA).

Surgical Protocol
After sterile draping, a midline laparotomy was performed. The skin was
retracted with traction sutures and the intestines were displaced to the right side and
wrapped in laparotomy sponges moistened with cold sterile saline. Isolation of the
abdominal aorta from the surrounding tissues from below the left renal artery to the iliac
biftircation was performed meticulously to avoid accidental injury to the inferior vena
cava and its branches. Care was taken to identify all aortic branches along the entire
circumference. If feasible, anastomotic sites were planned to avoid cutting of the large
dorsal aortic branches. Once all dissection was completed, one ml of heparin was
administered i.v. (1000 USP units/ml, American Pharmaceutical Partners, Inc., Los
Angeles, CA, USA) and if necessary, further cooling of the animal was achieved by using
sterile saline slush applied directly into the abdominal cavity and to the laparotomy
sponge covering the intestines.
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When the rectal temperature of the animal reached 34.5°C, the ice packs and the
saline slush were removed as the temperature continued to drop without additional
cooling. The cold supplemented Lactated Ringer’s solution was exchanged for warm
(37°C). Also, warm packs were placed next to the rabbit under the sterile draping and the
heating pad under the rabbit was switched on to start the re-warming phase of the
procedure initiating the re-warming period of the surgery.
Dorsal aortic branches within the previously prepared aortic segment were clipped
and cut. The aorta was occluded proximally and distally with micro-surgical vascular
clamps (MORIA 200/A, Angled, 30mm. Fine Science Tools, Inc. Foster City, CA, USA)
placed below the left renal artery and above the inferior mesenteric artery. And keeping
in mind the elastic recoil of the vessel, the aorta was cut approximately 1 cm from each
clamp to avoid space issues.
All animals had a Corograft™ (~3-4mm ID x ~4cm minimum) previously re
hydrated in heparinized saline, implanted into the inffarenal abdominal aorta. An end-toend anastomosis (distal then proximal) was performed with a continuous single

8 /0

Prolene suture (Polypropylene, Ethicon, Inc., Somerville, NJ, USA). Before tying the
suture for the proximal anastomosis, the distal vascular clamp was removed to flush air
from the graft by filling the graft with blood to avoid an air embolism. After tying the
suture, the proximal vascular clamp was removed and additional 8/0 Prolene suture used
(as needed) to control anastomotic or graft bleeding.
The intestines were returned to the abdominal cavity and repeatedly lavaged with
warm sterile saline to achieve appropriate re-warming of the animal. When the rectal
temperature o f the rabbit reached 36.5°C to 37.5°C, the saline was removed and the
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laparotomy closed in two layers with 3/0 Vicryl (Polygalactin 910, Ethicon, Inc.,
Somerville, NJ, USA). The supplemented Lactated Ringer’s solution was discontinued,
with a total amount of 100-150ml having been administered for both the cold and warm
solutions. When the animal was re-warmed to physiological temperature (101-104°F/3840°C) and movement was seen in the hind-limbs, the animal was returned to its’ cage.
Rabbits received 0.2ml flunixin meglumine (50mg/ml, Equileve®, Phoenix
Scientific, Inc., St. Joseph, MO, USA) i.m. as an analgesic immediately after surgery, and
0.2ml i.m. flunixin meglumine BID for 4 days post-operatively. All rabbits were
monitored for neurologic or ischemic complications of the hind limbs throughout the
study. No antibiotic prophylaxis, platelet aggregation inhibitors nor antieoagulants were
used postoperatively.

Sacrifice
The animals were sedated and brought to a full surgical plane of anesthesia. The
abdominal incision was re-opened and the graft dissected from surrounding tissues. Once
isolated, the rabbits were fully heparinized and then sacrificed. The graft was then
excised en-bloc and placed into Histo-Choice Tissue Fixative MB (Amresco Inc., Solon,
Ohio, USA) for a minimum of 24hrs before further processing.

Macroscopic Examination
Excess non-adherent tissue/fat was trimmed from the exterior of the graft and the
graft was photographed with markers plaeed indicating the suture lines and direction of
flow. Each graft was evaluated macroscopically for aneurysmatic changes (indicated by
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an area of vessel wall ballooning outwards and being of a greater diameter than the
originally implanted graft), atherosclerotic lesions, thrombus, or any other obvious
abnormalities.

Histology
Samples (2-3mm) cut from the center of the graft were dehydrated and embedded
in PolyFin wax (Polysciences, Inc., Warrington, Pennsylvania, USA), sectioned at 5jim,
and collected on slides coated with poly-L-lysine (Sigma Chemical Co., St. Louis, MO,
USA) or charged slides (Superfrost® plus, VWR Scientific, West Chester, PA, USA).
Representative sections were stained with hematoxylin and eosin (H&E) for general
tissue/cellular morphology, Masson’s Trichrome for collagen and Movat’s Pentachrome
stain for collagen and elastin.

Immunohistology
Slides for immunohistology were prepared as above. Representative sections
were stained for a-smooth muscle cell actin (a smooth muscle cell/myofibroblast
marker), CD3 (pan-T cell antibody) and RAM 11 (rabbit macrophage-specific antibody).
Sections stained for a-SMC actin were deparaffinized, treated with 3% H 2O2 for 5min to
remove endogenous peroxidases, rinsed with dH2 0 and blocked with 0.05% Tween-20
(Sigma Chemical Co., St. Louis, Missouri, USA) in phosphate buffered saline (PBS-T)
for 30min. The slides were incubated for 30min with the appropriate primary antibody
diluted in PBS-T, then rinsed with PBS-T. Sections stained for a-actin were incubated
with Protein A-horseradish peroxidase (Sigma Chemical Co., St. Louis, Missouri, USA),
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1:500 dilution in PBS-T for 30min. Sections stained for rabbit macrophages (RAM 11)
and T cells (CD3) were treated with the components of the LSAB-2 biotin-streptavidin
amplification kit (DAKO, Carpinteria, California, USA) according to the supplied
instructions with the incorporation of an avidin^iotin blocking procedure. All
incubations were carried out in a moist chamber at room temperature. Sections were
rinsed with PBS-T and developed by the addition of lOOp.1 of DAB substrate (Sigma Fast
DAB, Sigma Chemical Co., St. Louis, Missouri, USA) per slide. The development was
stopped with water and the slides counterstained with H&E or hematoxylin alone. The
slides were dehydrated, cleared and coverslipped.
Antibody to;
a-Smooth Muscle Cell Actin
Rabbit Macrophage
T Cell/CD3

Clone
1A4
RAM 11
Rbt poly

Dilution
1:400
1:500
1:50

Development
Protein A-HRP
LSAB-2
LSAB-2

Source
Sigma
Dako
Dako

Macrophage Counts
Macrophages are involved in the inflammatory response toward the graft and in
the development and progression of atherosclerosis, and the numbers present were used
as an indirect indicator of disease severity and inflammation. Slides stained with the
RAMI 1 antibody were used in this portion of the study. Five random lOOX fields were
photographed at the junction between graft tissue and ablumenal tissue where the
majority of the macrophages were loeated. The number of macrophages and giant cells
were counted per image and averaged to obtain the count.
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Zymography
Matrix metalloproteinases (MMPs) are produced by macrophages and other cell
types as part of an inflammatory response and could be involved in graft degeneration,
therefore pre- and post-operative serum samples were qualitatively evaluated for
circulating MMP levels. The conditions present during zymography allow for the
detection of both the pro-forms and activated MMPs, due to the dissociation of the active
MMPs from inhibitors or the spontaneous activation o f zymogens
Serum samples were electrophoresed on 10% polyacrylamide gels containing
1mg/ml Gelatin or Elastin. The samples were diluted 1:10 (v:v) with saline and then 1:1
with 2X Non-denaturing Sample Buffer (no (3-Mercaptoethanol), 20pl loaded onto the
gel and run at 200 V until completion. The gels were washed 2X 30 min with 2.5%
Triton X-lOO/dHaO with agitation, washed 30 min with RT Activation Buffer with
agitation, and then incubated 0/N in Activation Buffer at 37°C with agitation
(Activation buffer 25mM Tris, lOmM CaCb, IpM ZnCli, 50mM NaCl, pH 7.5). Gels
were stained with coomassie brilliant blue and areas of gelatinolytic or elastolytic activity
were seen as clear bands against a blue background. The gels were then visually
inspected for differences.
MMP activity was confirmed by incubating the gels in the presence o f Immol/L
1,10-phenantroline (MMP inhibitor) in the activation buffer in both the 30 minute wash
and overnight incubation
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ELISA for Humoral Response
Dry graft material was lyophilized to a constant weight, suspended in 1% acetic
acid at a concentration of Img/ml (w/v) and homogenized. The material was diluted to
~250ug/ml with 0.02M Carbonate buffer (pH 9.6) and lOOul (~25ug/well) of collagen
was added to each well o f a 96-well plate (Falcon PRO-BIND™, Becton Dickinson and
Company, Franklin Lakes, NJ, USA). The plates were evaporated to dryness overnight at
room temperature in a hood. Before use, the plates were washed 4X with PBS-T and
blocked for 45 min RT (or O/N at 4°C) with lOOul PBS-T/1% BSA per well. The wells
were then rinsed 4X with PBS-T and serial 2-fold dilutions of serum were plated in
PBS/1% BSA (50ul/well in duplicate). The plates were incubated at RT for Ihr and
washed 4X with PBS-T. Anti-Rabbit IgG-HRP (Monoclonal Anti-Rabbit IgG y-chain
specific. Clone RG-96, Peroxidase Conjugate A-1949, Sigma-Aldrich Co, St Louis, MO,
USA) was diluted 1:40,000 in PBS-T/1% BSA and 50ul/well was added. The plate was
incubated 2hrs at RT and washed 4X with PBS-T. OPD substrate (HRP substrate, Dako
Corporation, Carpinteria, CA, USA) was prepared according to the manufacturers
instructions (dissolved in room temperature dHaO and 30% H2 O2 added) and 50ul of the
substrate solution was added to each well. The color was allowed to develop BOmin at
room temperature and the reaction stopped by the addition of 50ul of 0.5M H2 SO4 to each
well. The absorbance was read at 490nm in a microplate reader (Opsys MR, Dynex
Technologies, Chantilly, VA, USA).
Normal rabbit serum was included as the negative control and the values obtained
used to adjust for serum absorbance. In all cases the OD value from the normal rabbit
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serum was subtracted from the mean valued obtained for the corresponding dilutions of
the experimental samples. The titer listed is derived from the last well giving a positive
OD after adjustment. Blank values were obtained from wells incubated with PBS-T/1%
BSA instead o f serum and subtracted from all OD values by the microplate reader
software.
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Results
Post-Operative Survival and Graft Patency
Normal Diet Rabbits: Thirteen female New Zealand White rabbits were operated and a
small-diameter bovine conduit (intemal diameter of 3-4mm) was implanted into the
inffarenal abdominal aorta. All grafts were patent immediately after implantation as
demonstrated by a visible and palpable pulse, and at saerifice at 2 (n=3), 4 (n=4), and

6

months (n=3).
Hind-limb paraparesis developed in one rabbit within the first postoperative day
and the animal died the third postoperative day. One rabbit became ischemic and was
euthanized six days post-operatively. Post-mortem examination did not show graft
occlusion. One animal developed bilateral dry ulcerations of the footpad. One rabbit
died suddenly at 5 months and post-mortem examination revealed intestinal ischemia and
graft thrombosis.

Cholesterol Diet Rabbits: Sixteen rabbits were operated and had a small-diameter
bovine conduit (intemal diameter o f 3-4mm) was implanted into the inffarenal abdominal
aorta. All grafts were patent immediately after implantation as demonstrated by a visible
and palpable pulse. Two rabbits died perioperatively due to complications with
anesthesia, one was euthanized due to a spinal injury, and two were euthanized due to
paralysis on day 2 and day 4. Five rabbits died on day 1(n=2), day 2 (n=2), and day 3
(n=l) of unknown causes. Five additional rabbits died o f a massive hemorrhage on day
6,

14, 15, 20, and 46. One rabbit survived to 73 days and was sacrificed.
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Normal diet samples macroscopic
Normal Diet 2 months: Vascular grafts (Corograft™, L and D-Hydro™ treated bovine
artery) implanted into the abdominal aorta of the three rabbits (G5824, G5827, and
G5828) were slightly dilated on explant. One explanted graft (G5824) had an
outpocketing near the distal suture line, the second graft (G5827) had the same and a few
thin portions of the graft wall, and the third graft (G5828) did not have any visible thin
spots, but the proximal suture line was constricted (Figure 1-1: 2Mo Macroscopic).

Normal Diet 4 months: One graft (G5586) appeared normal, with a diameter slightly
larger than the abdominal aorta, the other three grafts (G5830, G5831, G5832) had large
dilated areas, but did not appear to be aneurysmatic (Figure 1-2: 4Mo Macroscopic).

Normal Diet 6 months: The three explanted grafts (G5581, G5587, and G5588) were
normal in appearance, with no visible areas of dilation (Figure 1-3: 6Mo Macroscopic).

Un-Implanted Graft Histology
Re-hydrated, un-implanted Corograft™ material was fixed, paraffin embedded, sectioned,
and stained with H&E (Figure 2: Corograft™ Histology). The histology shows the
structures present in a healthy small artery. The graft intima extends from the internal
elastic lamina to the lumenal surface, and after processing the graft material is devoid of
endothelial cells and only the basement membrane remains. The media is defined by the
internal elastic lamina and the more diffuse external elastic lamina and contains
collagenous fibers, elastic fibers and remnants of smooth muscle cells arranged in a
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Figure 1-1: Macroscopic evaluation of samples cxplantcd from 2 month normal diet
rabbits. Excess tissue was trimmed from the graft exterior and the graft photographed.
The graft was then opened longitudinally along the ventral aspect, pinned open and
photographed. Any aneurysmatic changes, atherosclerotic lesions, thrombus, or areas of
dilation were noted. Grafts are shown in both an extemal and internal view. All grafts
were slightly dilated upon explant. Several areas of 05824 and 05827 were more dilated
and appeared as outpocketings (*). Diagonal arrows indicate the constriction of the
proximal suture line in 05828. t Arrows indicate the suture lines. ->■ Arrow indicates
the direction of blood flow.
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Figure 1-1:2 month Macroscopic
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Figure 1-2: Macroscopic evaluation of samples explanted from 4 month normal diet
rabbits. Excess tissue was trimmed from the graft exterior and the graft pbotograpbed.
The graft was then opened longitudinally along the ventral aspect of the graft, punned
open and pbotograpbed. Any aneurysmatic changes, atherosclerotic lesions, thrombus, or
areas of dilation were noted. Grafts are shown in both an extemal and intemal view. All
grafts were dilated on explant and G5830, G5831 and G5832 bad further areas of areas of
dilation that appeared as outpocketings (*). tA rrow s indicate the suture lines. ->• Arrow
indicates the direction o f blood flow.
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Figure 1-2: 4 month macroscopic

K u b b i t Ui i ' y - 6

4 ii’on th s

'2

Uahbii ?'<;
4 montlvb 2/1'* -

Itahbit Mi 5S.U
1 inniJtbs 2/4AU

B.ibbit #G SS86' ,
4 months 1/25/02

Kahhit m 5N.10
4 niidifhs 2/1/1

R abbit
5831
/ 4 m o n t h s 2 /4 /0 2

^

KsiM'it Mi

4months lj2S/h2

bbit >Y-

m o n t h s l /2o '0 2

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 1-3: Macroscopic evaluation of samples cxplantcd from 6 month normal diet
rabbits. Excess tissue was trimmed from the graft exterior and the graft photographed.
The graft was then opened longitudinally along the ventral aspect of the graft, punned
open and photographed. Any aneurysmatic changes, atherosclerotic lesions, thrombus, or
areas o f dilation were noted. Grafts are shown in both an extemal and intemal view.
None of the explanted grafts were dilated upon examination, t Arrows indicate the
suture lines.

Arrow indicates the direction of blood flow.
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Figure 1-3:6 month macroscopic
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circumferential manner. The adventitia is located ablumenal to the extemal elastic
lamina where the collagenous fibers appear more longitudinal, have a looser arrangement
and are interspersed with elastin fibers that appear more globular in cross section. The
nuclei seen within the graft tissue are remnants from the original cells, as this graft is not
extracted with detergents or enzymes to remove these cellular components. All further
descriptions of implanted graft material will be described with respect to these stmctures,
and where possible the original graft material will be differentiated from host-derived
cellular ingrowth and tissue deposition.

Histology of Explanted Samples from Normal diet Rabbits
Normal Diet 2 Months (Figure 3: 2Mo Histology)
The graft matrix was well preserved in G5824 and less organized in G5727 and G5828,
and was re-colonized by host cells in all samples. An ablumenal layer of tissue was
present to the exterior o f the grafts composed of loose collagenous tissue, blood vessels,
adipose tissue, some giant cells and various other cells. The graft from G5824 had a
layer of tissue of variable thickness present on the lumenal surface of the graft that
contained some red and white blood cells (Fig. 3-lA). In G5824 and G5828, a thin layer
o f cells staining for a-smooth muscle cells actin were seen located on and just below the
lumenal surface o f the graft, and were present for about a third of the circumference (Fig.
3-2A&C). Additional weak actin staining was seen within the graft tissue, but appeared
to be remnants of the original actin present prior to processing, as staining was not welldefined, non-specific in nature, not limited to specific cells, and present in the areas
comprising the original media. In G5827, the actin staining was confined to several small
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Figure 2; H&E of reconstituted unimplanted Corograft™ material. The three major
layers o f a small artery are clearly visible: the intima, media, and adventitia. The
graft intima is composed o f the basement membrane sitting on top of the intemal
elastic lamina. The media is defined by the intemal and extemal elastic laminae.
The adventitia is located ablumenal to the extemal elastic lamina. Collagen stains
pink, Elastin does not stain and appears as translucent refractive stmctures.
lEL, Intemal Elastic Lamina; ExEL, Extemal Elastic Lamina; CF,Collagen Fibers;
EF,Elastic Fibers; BM, Basement Membrane.
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Figure 2; Unimplanted Corograft Histology
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blood vessels in the adventitia and the occasional actin remnant within the graft (Fig. 32B). In G5824 and G5827, macrophages and giant cells were located at the interface
between the graft tissue and the ablumenal layer, and in G5828 formed a complete ring
around the graft tissue and were also bound to about a third of the lumenal surface on the
more ventral aspect o f the graft (Fig. 3-1 A, B and C). Trichrome staining showed
relatively well preserved/organized collagen within the graft in G5824 with some more
lightly stained area which appeared to be expanded due to cellular ingrowth, while in
G5827 and G5828 the graft collagen was expanded and interspersed with less mature
collagen, and little o f the original collagen remained (Fig. 3-3 A, B and C). Movats of
G5824 showed that elastin was present within the graft tissue and the intemal elastic
lamina was present. In G5827 and G5828, the intemal elastic lamina was no longer
present, elastin fibrils were present in the medial (circumferential) layer, but the majority
of the adventitial (longitudinal) layer and associated elastin was present in G5828 but
missing in G5827. CD3+ cells were present within the ablumenal layer scattered
throughout the tissue.

Normal Diet 4 Months (Figure 4: 4Mo Histology)
The graft matrix was well preserved in all samples, and appeared as two distinct layers, a
more cellular medial layer lumenally and a less cellular adventitial layer more ablumenal.
For samples G5586 and G5830, the graft was reeolonized with cells throughout the
thickness with the majority o f the cells present within the medial layer, while in G5831
and G5832 the cellularity was evenly distributed throughout the graft tissue (Fig. 4 -lA to
D). A relatively thin layer o f tissue was present to the exterior of the
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Figure 3-1: 2 month normal diet samples were embedded and 5pm sections were stained
with H&E for general tissue morphology and cellularity. All grafts were re-colonized by
host-derived cells. All grafts had a host-derived ablumenal layer containing loose
collagenous tissue, blood vessels, adipose tissue, some giant cells and various other cells
(Ab). G5824 had a luminal layer containing some red and white blood cells (f). G5824,
G5827 and G5828 had macrophages and giant cells ( |) located at the interface between
the graft and the ablumenal tissue. Scale bar -lOOpm.
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Figure 3-1: H&E stain of 2 month samples
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Figure 3-2:2 month normal diet samples were embedded and 5pm sections were stained
for a-smooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The
presence of aetin-staining cells would indicate the presence of host-derived
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in
blood vessels). G5824 and G5828 had a thin layer of cells staining for a-smooth muscle
cell actin on and just below the lumenal surface of the graft (f). Additional weak actin
staining was seen within the graft tissue, but appeared to be remnants of the original actin
present prior to processing (*). In G5827, the aetin staining was confined to several
small blood vessels in the adventitia and the oeeasional actin remnant within the graft.
Scale bar ~100pm.
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Figure 3-2: Actin stain of 2 month samples
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Figure 3-3:2 month normal diet samples were embedded and 5 pm sections were stained
by Massons Trichrome. This stain is for collagen integrity and organization. The darker
blue collagen is considered more mature, while lighter staining collagen is considered
indicative of less mature collagen. Trichrome staining showed relatively well
preserved/organized collagen within the grafts and more lightly stained areas of
remodeled collagen (open circles).
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Figure 3-3: Trichrome stain of 2 month samples
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graft composed o f loose collagenous tissue containing blood vessels, adipose tissue, some
giant cells and various other cells. There appeared to be a greater concentration of
inflammatory-type cells present at the junction between the graft tissue and the ablumenal
layer in G5586, and in G5830, G5831 and G5832 inflammatory cells were present as
small collections (Fig. 4-lA to D). A very thin layer o f bland looking material was
present on the lumenal surface of the graft from G5586. In G5832 a thin layer of clot
was seen on 2 portions o f lumen overlaying a layer o f fibrin material containing PMNs
(Fig. 4-lD). A thin layer of actin staining-cells was located at the lumenal surface for
about ~3/4 o f the circumference in G5586, G5830, and G5832 (Fig. 4-2A to C). Some
actin staining cells were present within the graft tissue extending for ~l/2 of the
circumference in G5586 and G5830. In G5832 approximately l/5th of the graft
contained actin staining cells. In G5831, a few actin staining cells were present within
the graft tissue, and some staining was seen ablumenally (Fig. 4-2C). Macrophages and
giant cells were located at the interface between the graft tissue and the ablumenal layer
and formed a complete ring aroimd the graft in G5586 (Fig. 4-lA). In G5830
macrophages and giant cells were located at the interface between the graft tissue and the
ablumenal layer, but fewer in number than previous samples and did not stain very
darkly. However more giant cells were seen within the graft tissue located in the medial
(circumferential) layer or on the lumenal surface. In G5831 scattered macrophages were
present in the ablumenal layer and some macrophages were bound to the lumenal surface
of the graft, few giant cells were present and were located at the edge of the graft. In
G5832 macrophages and a few giant cells were located at the interface between the graft
tissue and ablumenal layer and macrophages were seen within the surface fibrin layer.
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Trichrome staining of G5586 and G5830 showed the majority o f the collagen present was
lightly stained and appeared to be expanded due to cellular ingrowth (Fig. 4-3A&B). In
G5831, Trichrome staining showed the majority of the collagen present was well
preserved and mature fibrils were present more ablumenally. The remainder was lightly
stained and appeared to be expanded due to cellular ingrowth (Fig. 4-3C). In G5832,
Trichrome staining showed a band of more mature collagen at the lumenal surface while
the more ablumenal layer was composed primarily of lightly stained collagenous material
(Fig. 4-3D). Movats staining o f G5586 showed that thicker elastin fibrils were present
within the medial (circumferential) graft tissue and elastin was abundant within the
longitudinal tissue. Several portions of the intemal elastic lamina were still visible.
Movats staining of 5830 and 5831 (5832 H&E) showed that little elastin was present and
what remained appeared to be remnants of the original graft elastin. No intemal elastic
lamina visible was visible in these samples. All samples had CD3 + cell present within
the ablumenal layer scattered throughout the tissue.

Normal Diet 6 Months (Figure 5: 6Mo Histology)
The graft matrix of all samples was relatively well preserved, appearing as two distinct
layers medial (circumferential) and adventitial (longitudinal) for most of the implant,
with cellularity that was evenly distributed between the layers. Graft G5587 had two
large collections of fibrinous tissue adherent to the lumenal surface that occupied about
1/3 of the surface and protmded into the lumen of graft. A relatively thin ablumenal
layer was present to the exterior o f the graft composed of loose collagenous tissue
containing blood vessels, adipose tissue, few to no giant cells and various other cells.
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Figure 4-1:4 month normal diet samples were embedded and 5pm sections were stained
with H&E for general tissue morphology and cellularity. All grafts were re-colonized by
host-derived cells and had an ablumenal layer of tissue containing blood vessels and
adipose tissue. Inflammatory cells were seen within the ablumenal tissue and
representative areas are enclosed within the circles. G5832 had a thin layer of luminal
clot containing PMNs (f). Macrophages and giant cells were located at the interface
between the graft tissue and the ablumenal tissue in all grafts (f). Scale bar ~100pm
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Figure 4-1: FI&E of 4 month normal diet
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Figure 4-2: 4 month normal diet samples were embedded and 5pm sections were stained
for a-smooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The
presence o f actin-staining cells would indicate the presence of host-derived
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in
blood vessels). A thin layer of actin staining-cells was located at the lumenal surface in
G5586, G5830, and G5832 ( |) and varying amount of actin staining cells were seen
within the graft tissue of all sample
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Figure 4-2: Actin stain of 4 month normal diet
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Figure 4-3: Trichrome stain o f 4 month normal diet samples. Five pm sections were
stained by the Trichrome method of Masson. This stain is for collagen integrity and
organization. The darker blue collagen is considered more mature, while lighter staining
collagen is considered indicative of less mature collagen. Trichrome staining of G5586
and G5830 showed the collagen appeared to be expanded due to cellular ingrowth (open
circle). In G5831, Trichrome staining showed the majority of the collagen present was
well preserved and the remainder was appeared expanded due to cellular ingrowth (open
circle). In G5832, Trichrome staining showed a band of more mature collagen at the
lumenal surface while the more ablumenal layer was composed primarily of lightly
stained collagenous material (open circle). Scale bar -lOOpm.
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Figure 4-3: Trichrome stain of 4 month normal diet
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There were few inflammatory-type cells present at the junction between the graft tissue
and the ablumenal layer (Fig. 5-lA to C). No apparent actin staining was seen within the
grafts from G5581 and G5588, while an occasional cell was stained for actin in G5587
(Fig. 5-1A to C). Few blood vessels were present and stained for actin in the ablumenal
layer. Scattered macrophages were present in the ablumenal layer but few giant cells
were present. A few macrophages were bound to the lumenal surface of the grafts, and
were also present near the surface o f the fibrinous tissue in G5587. Trichrome staining of
G5581 showed the majority of the collagen present was well preserved and mature fibrils
were present in the ablumenal layer (Fig. 5-3A). The remainder was lightly stained and
appears to be expanded due to cellular ingrowth. Trichrome staining of G5587 showed
the majority of the collagen present was lightly stained and appears to be expanded due to
cellular ingrowth (Fig. 5-3B). Trichrome staining of G5588 showed a minority of the
collagen present was as mature fibrils that appeared to be remnants of the original graft
(Fig. 5-3C). The remainder was lightly stained and appeared to be expanded due to
cellular ingrowth. Movats of G5581 and G5587 showed that a few elastin fibrils were
present, but appeared to be remnants o f original graft elastin in the adventitial
(longitudinal) layer. Fragments of the internal elastic lamina were visible in G5581 and
5587, but absent in G5588. CD3 + cells were present scattered throughout the ablumenal
layer.

Cholesterol-diet samples macroscopic
Cholesterol Diet 2 months: The graft from the single cholesterol diet rabbit (G6185)
appeared dilated, with a large outpocketing just below the proximal suture line where
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Figure 5-1: H&E stain of 6 month normal diet samples. Five pm sections were stained
with H&E for general tissue morphology and cellularity. The graft matrix of all samples
was well preserved and appeared as two distinct layers that were re-colonized by hostderived cells. All grafts had a relatively thin ablumenal layer exterior to the graft
material composed o f loose collagenous tissue containing blood vessels, adipose tissue,
scattered macrophages and a few inflammatory-type cells (circles).
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Figure 5-1: H&E stain of 6 month normal diet
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Figure 5-2: Actin stain o f 6 month normal diet samples. Five pm sections were stained
for a-smooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The
presence of actin-staining cells would indicate the presence of host-derived
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in
blood vessels). No apparent actin staining within the grafts from G5581 and G5588,
while an occasional cells was stained for actin in G5587 (*).
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Figure 5-2: Actin stain of 6 month normal diet
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Figure 5-3: Trichrome stain of 6 month normal diet samples. Five pm sections were
stained by the Trichrome method of Masson. This stain is for collagen integrity and
organization. The darker blue collagen is considered more mature, while lighter staining
collagen is considered indicative of less mature collagen. Trichrome staining of G5581
and G5587 shows a portion of the collagen was well preserved and the remainder appears
expanded due to cellular ingrowth (open circle). Trichrome staining o f G5588 showed a
minority o f the collagen present was as mature fibrils that appeared to be remnants of the
original graft (*). The remainder was lightly stained and appeared to be expanded due to
cellular ingrowth (open circle).
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Figure 5-3: Trichrome stain of 6 month normal diet
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wall of the graft was thinner than the remainder (Figure 6A and B): Cholesterol diet
Macroscopic).

Cholesterol diet Macroscopic Aneurysm samples (Figure 6C to F)
Five cholesterol-diet rabbits died postoperatively on days 6,14,15, 20, and 46. Post
mortem examination revealed the presence of a massive hemorrhage either into the
abdominal cavity or retroperitoneally due to an apparent graft rupture.

Cholesterol-diet Histology
2 Months (Figure 7-1: 2Mo Histology)
Graft matrix was unorganized, and less cellular than the normal counterparts. The
ablumenal layer contained very loose collagenous tissue, blood vessels, some adipose
tissue, as well as many giant cells and a several large patches of inflammatory cells. The
medial layer appeared expanded, while the adventitial layer was a thick layer o f very
loose tissue containing many cells with large cytoplasmic areas containing translucent
granular material that appear to be foam cells (Fig. 7-lA). A thin layer of actin stainingcells were located at or on the lumenal surface staining for about a third of the
circumference (Fig. 7-lB). Actin staining was also seen in two small blood vessels in the
adventitia and the occasional actin remnant within the graft. Giant cells, macrophages
and foam cells were located within the expanded adventitial tissue. Macrophages also
formed an almost complete layer at the lumenal surface of the graft (Fig. 7-lA).
Trichrome indicated that the majority of the graft collagen was degraded and what
remained was mainly less mature collagen with a filamentous appearance (Fig. 7-lC).
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Figure 6: Macroscopic evaluation of cholesterol diet samples. Panels A&B are
photographs o f the graft harvested from the cholesterol diet rabbit at 2 months and shows
the outpocketing o f the graft near the proximal suture line (*). Panels C to F are
aneurysm samples at 6 ,1 4 ,1 5 ,2 0 and 46 days respectively. The area o f rupture for these
samples is indicted by the | arrows, tA rrow s indicate the suture lines and the flow of
blood is fi'om left to right.
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Figure 6: Cholesterol Diet and Aneurysm Samples Macroscopic
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The majority o f the internal elastic lamina was present with fine filamentous elastin
fibrils present in the expanded medial (circumferential) layer with no apparent
organization. Single scattered CD3+ cells and several small groupings were present in
the ablumenal layer.

Rabbits (Figure 7-2: Cholesterol Diet Aneurysm Histology)
Extensive collagen and elastin firagmentation was seen in all samples (Figure 7-2A, C, E
and I). In all cases, the normal vessel architecture was disrupted due to the infiltration of
the graft matrix by numerous macrophage/foam cells (Figure 7-2B, D, F and J). No
evidence o f actin staining was seen in any o f the samples except in the occasional
ablumenal blood vessel. The internal elastic lamina was still intact in the 6 and 14 day
samples, but was fragmented in the 15, 20, and 46 day samples. The adventitial elastin
was degraded in 14, 15, 20 and 46 day samples. In one case (15 day sample)
extravascular blood was seen within the graft matrix. The graft matrix in these samples
resembled atheroma that developed in the thoracic artery (Figure 7-3: Atheroma).

Macrophage Counts
Slides stained with RAMI 1, a rabbit-macrophage-specific antibody, were used in
this portion of the study. Photographs of 5 high-power fields were taken at the junction
o f the graft adventitial tissue and the ablumenal layer where macrophages/giant cells
were common. If possible, the field contained a portion of the graft adventitial tissue.
The macrophage counts from the five random lOOX fields were averaged for each
sample, and the mean number of macrophages per group generated from these values.
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Figure 7-1: Histology o f 2 month cholesterol diet sample. Panel A is the H&E stain of
the graft. The graft matrix was less cellular than the normal coimterparts at 2 months and
the graft material was expanded. Giant cells, macrophages and foam cells were located
within the expanded adventitial tissue (M). Macrophages also formed an almost
complete layer at the lumenal surface o f the graft (*). Panel B is the actin stain of the
graft and shows a thin layer of actin staining-cells located at or on the lumenal surface
(f). Panel C is the Trichrome showing that the majority of the graft collagen was
degraded and had a filamentous appearance (open circle). Scale Bar -lOOpm

94

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Figure 7-1: H&E, Actin and Trichrome of 2 month Cholesterol Diet Graft
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Figure 7-2: Cholesterol Diet Aneurysm Histology. Panels A, C, E, G and I are H&E
stains of the samples. In all samples the collagenous graft material has been degraded and
a cellular influx is seen in all samples. These cells are presumably macrophage derived
foam cell based on the cellular morphology and foamy-looking cytoplasm. Panel B, D, F
and J are RAMI 1 macrophage stains, confirming the identity of these cells as
macrophages (open circles).
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Figure 7-2: Aneurysm Flistology
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Figure 7-3: Histology of the thoracic aorta from normal and atherosclerotic rabbits.
In panel A the histology o f a normal rabbit thoracic artery is visible showing the
Intima (*Endothelial cells), Media and Adventitia. Panels B and C show a well
developed Atheroma in a rabbit thoracic aorta stained with H&E for morphology
and RAMI 1 for macrophages, respectively. The layers of the artery are visible,
though little evidence of the aortic intima remains. The atheroma has developed
above the internal elastic lamina (lEL) and protrudes into the lumen. The
atheroma is dominated by foam cells and extraeellular matrix, giving it a loose,
disorganized appearance. The inset shows the foam cells (granular, vacuolated
cytoplasm) and extracellular matrix in more detail. Scale bar -lOOpm
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Figure 7-3: Normal and Atherosclerotic Aorta
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No statistically significant differences were seen between 2 ,4 and 6 month
samples from rabbits fed a normal diet. Cholesterol diet samples from aneurysm samples
showed numerous macrophages but could not be counted due to overlap. The
macrophage count from the cholesterol diet rabbit sacrificed at 2 months was similar to
the normal diet samples and was not significantly different.

Zymography
No major observable differences in band intensity were seen between surgery and
sacrifice samples (Figure 8: Zymograms). The MMP profile did not change between
groups, or between normal diet and cholesterol diet. Development in the presence of
1,10-phenanthroline MMP inhibitor indicated that the majority of the gelatinolytic
activity was due to MMPs, with very little due to proteases (data not shown).

Humoral ELISA (Host Humoral Immune Response toward Graft)
In all cases the humoral response to the graft increased between surgery and sacrifice
(Table 4: ELISA Titers). The overall trend over the 6 month period was a reduction in
the humoral response toward the graft material (Figure 9: Log ELISA). No statistical
significance could be determined between groups as the number of samples in each group
were too few.
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Table 3; Macrophage counts were done on slides stained for RAMI 1 from normal and
cholesterol diet samples. Five high-power fields were photographed at the junction o f the
graft material and the ablumenal host tissue where the majority of the macrophages were
located. The macrophages were manually counted, and the number averaged to obtain
the given values. No significant differences were seen between groups. Values are Mean
±SEM
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Table 3: Macrophage Counts - Diet
Rabbit #

Diet

G5824 2 month
Normal
G5827 2 month
Normal
G5828 2 month
Normal
G5586 4 month
Normal
G5830 4 month
Normal
G5831 4 month
Normal
G5832 4 month
Normal
G5581 6 month
Normal
G5587 6 month
Normal
Normal
G5588 6 month
G6185 2 month
Cholesterol
Cholesterol
G6409 6 dayt
Cholesterol
G6405 14 dayt
Cholesterol
G6186 15 dayt
Cholesterol
G6183 20 dayt
Cholesterol
G6182 46 dayt
Average of 5 high-power fields

A vg#of
Macrophages
42.6
19.2
18.6
41.2
22
27.4
17.6
41.6
33.6
38.4
34.8
TNTC
TNTC
TNTC
TNTC
TNTC

Mean # of
Macrophages^
26.8+7.9

27.05+5.1

37.8±8.1

Mean ± SEM
TNTC - Too numerous to count
ND - Not done
tAneurysm Samples
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34.8
ND
ND
ND
ND
ND

Figure 8: To analyze differences in MMP presence or expression between surgery and
sacrifice samples, equivalent amounts of serum were electrophoresed on 10% acrylamide
gels containing 1% gelatin. The gels were run to completion, washed to remove SDS,
and incubated in activation buffer (with and without MMP inhibitor) for the appropriate
time. Gels were stained with coomassie brilliant blue, and active bands appear as clear
bands on a blue background. No observable differences were seen within or between
groups, or between diet types for all rabbits. *Cholesterol diet
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Figure 8: Zymograms of 2, 4 and 6 month Samples - Diet
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Table 4: Serum samples were collected and stored at -60°C until all had been collected
then the humoral response toward the graft material was quantified by the humoral
ELISA. Each sample was analyzed in duplicate, with each plate containing an internal
blank. All readings were averaged, adjusted for normal rabbit serum OD, and the
reciprocal given.
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Table 4: ELISA titers of 2 ,4 and 6 Month Samples - Diet
Rabbit #
G5824 Normal Diet 2Mo
G5827 Normal Diet 2Mo
G5828 Normal Diet 2Mo
G5586 Normal Diet 4Mo
G5830 Normal Diet 4Mo
G5832 Normal Diet 4Mo
G5831 Normal Diet 4Mo
G5588 Normal Diet 6Mo
G5581 Normal Diet 6Mo
G5587 Normal Diet 6Mo
G6185 Cholesterol Diet 2Mo

Titer @
Surgery
20
20
40
20
20
20
20
20
20
20
20

Titer @
Sacrifice
20480
10240
20480
640
1280
1280
20480
320
640
1280
20480
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Figure 9: The log of the ELISA titers were plotted to graphically show the differences
between the humoral response to the graft material at surgery and then at sacrifice. In all
cases there was an increased humoral response to the graft between surgery and sacrifice.
Over the 6 month period the overall trend shows a decreased humoral response toward
the graft material. No statistical significance could be determined as there were too few
samples in each group. Normal diet 2 month samples: G5824, G5827 and G5828.
Normal diet 4 month samples: G5586, G5830, G5831 and G5832. Normal diet 6 month
samples: G5581, G5587 and G5588. Cholesterol diet 2 month sample: G6185.
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Figure 9: Humoral ELISA of 2 ,4 and 6 Month Samples - Diet
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Table 5: The histology, immunohistology, macrophage counts, and ELISA information
were summarized to provide an overview of the results for the 2, 4 and 6 Month Samples.
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Table 5: Complied results for 2 ,4 and 6 month samples - Diet
Animal #
G5824
G5827
G5828
G6185

2mo
2mo
2mo
2mo*

Graft
Cellularitv
+
+++
+++
-/+

Actin
++
+
+
+

Collagen
Remodel
+
++
++
++++

Macrophage
Presence
+
+
++++
++

Tissue
Destruction

G5586
G5830
G5831
G5832

4mo
4mo
4mo
4mo

++
+
+
+

++++
++++
+
++

+++
+++
+
+

+
+
+
-

-

+++
+++
+++
++++

G5581 6mo
G5587 6mo
G5588 6mo

++
++
+

+
+
-

+++
+++
+++

+
+
-/+

-

++
+++
++

-

++++
-

Humoral
response
++++
++++
++++
++++

* Cholesterol Diet
Graft Cellularity -(0%) —» ++++ (100%) re-colonization o f graft material hy host cells.
Actin -(0%) —> ++++ (100%) recolonization o f graft media hy actin-positive cells.
Collagen Remodel -(0%)

++++ (90-100%) newly produced collagen vs. mature.

Macrophage Presence -(few macrophages) —^ ++++ (40-50) avg. # macrophages.
Tissue Destruction -(0%) —>++++ (100%) destruction of original graft material.
Humoral Response -(0%)

++++ (100%) of maximum response, rated relative to the

highest response seen for all grafts.
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Discussion
Effects of Atherosclerosis
With the need for alternative bypass conduits increasing each year, the effects of
hypercholesterolemia on non-autologous grafts needs to be studied, and grafts need to be
tested in a less-than-favorable environment to more accurately determine durability and
outcome. Many studies have implanted autologous, heterologous, xenogenic or synthetic
vascular grafts into the circulation of normal animals, while other studies have evaluated
the effect of an atherogenic diet on the development atherosclerosis. Few studies have
directly evaluated the effect of atherosclerosis on vascular grafts, and then the effect of
experimental atherosclerosis on autologous vein grafts

16 52 53

’ ’ or synthetic grafts

59 78

’ in

rabbits was examined.
Review of published literature shows little has been published on the effect of
experimental hypercholesterolemia on xenograft durability. This chapter addresses this
issue directly, and was designed to assess the role of inflammation on the graft material
by increasing inflammation via diet-induced atherosclerosis. Two groups of rabbits were
fed a normal diet or an atherogenic diet supplemented with cholesterol, allowing for the
evaluation of the long-term outcome of this graft in a disease model, which had not
previously been done. Weekly bleeds were done on both the normal and cholesterol diet
rabbits to monitor serum cholesterol levels and inclusion of cholesterol into the diet
resulted in a considerable elevation in pre-operative serum cholesterol compared to
rabbits fed a normal diet.
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Normal diet rabbits
Rabbits fed the normal diet recovered well from surgery and on explant at 2 ,4
and 6 months the grafts were found to be incorporated into the host. The grafts were
covered with host-derived tissue with little evidence fibrosis. Further microscopic
analysis o f the samples showed the graft material was re-colonized by host-derived cells.
However, macrophages were a common finding in the tissue surrounding the grafts and
giant cells and scattered T-cells were also present. This indicated that the graft material
did appear to elicit a chronic inflammatory type response, but the response was not severe
enough to result in graft failure. This could be considered an advantage as the
inflammatory response appears to promote the formation of new vessels that may support
the graft tissue. The healing of the grafts appeared to be ongoing out to 6 months and
longer studies would be interesting as they would show whether the graft becomes fully
incorporated into the host and develops a functional intima and media. Functional studies
could also be done to show whether the vessels becomes responsive to stimuli normally
present in the vasculature (vasodilatation and vasoconstriction).

Cholesterol diet rabbits
By comparison the majority of cholesterol-diet rabbits did not survive longer than
a few days post-operatively. The reasons for this are unclear, but may be a due to the
combined stress o f the surgery in conjunction with the systemic stress of atherosclerosis
resulting in the death of the animals. This could be explored by the addition of sham
surgeries as an experimental group, in which the entire surgical procedure including
cross-clamping the aorta for 30 minutes without implanting the graft, would be
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performed. This would allow us to evaluate the effect o f the surgery on post-operative
survival in hypercholesterolemic rabbits, and see whether the surgery is contributing to
the increased mortality.

The effects of hypercholesterolemia on the graft
Five of the rabbits that survived the immediate post-operative period died of a
burst aneurysm o f the graft material between 6 and 46 days. Microscopic examination of
these post-mortem aneurysm samples, as well as graft material from the single surviving
cholesterol-diet rabbit at 2 months, showed the presence of numerous foam cells, little
collagen and elastin, and extensive destruction of tissue architecture. The appearance o f
the expanded graft tissue as well as atheromatous plaque tissue harvested from the
thoracic aorta was very similar, and both contained numerous macrophage-derived foam
cells. The ubiquitous presence of foam cells and the lack of other cell types in the area of
the aneurysm, in conjunction with the graft tissue destruction in these areas, appears to
implicate these cells in the development and progression of the aneurysm leading to
rupture.
The histology data suggest that hypercholesterolemia is associated with an
increased presence o f foam cells and degradation of the graft material. This could lead to
graft degeneration as well as aneurysm formation and rupture, which could be due to the
increased production and activity of lytic enzymes by the macrophages in atherosclerotic
rabbits. Previously published studies have shown that hypercholesterolemia increases the
presence of macrophages within the aortic tissue of rabbits

C l 'y Q

’ ’ and withdrawal of

dietary cholesterol reduces the presence of macrophages within atherosclerotic lesions
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Atherosclerosis has been associated with the development of aneurysms due to an
increase in the inflammatory response and the production of lytic enzymes that degrade
extracellular matrix components

that are secreted by macrophages

.

The zymography data did not show an increase in circulating serum MMPs, but
the serum levels may not accurately reflect the levels of MMPs within the graft material.
Even though the presence of MMPs in serum is supposedly proportional to the amount in
tissue (at least in published studies of aneurysm formation), the serum samples collected
in this study may not truly reflect the MMP amount and activity within the graft tissue.
Additionally, the degeneration within the grafts is localized to a small portion of the
vasculature and the differences may not be detectable with the methodology employed.
Also, the MMP activity seen reflects the total amount of MMP present within the serum
and does not differentiate between what was originally active or inactive

Western

blotting of graft extracts or immunohistology o f graft sections for the presence and
relative amounts specific lytic enzymes known to degrade matrix components (such as
MMP2 and 9) could be used to explore the differences between the normal and
atherosclerotic grafts.

Graft durability in an atherosclerotic rabbit model
The grafts harvested from the one surviving rabbit fed an atherogenic diet and the
samples obtained from the cholesterol-diet rabbits that died from ruptured grafts provide
an interesting glimpse into the effect of atherosclerosis on graft durability and these
observations may directly apply to the failure o f grafts in human patients and merits
flirther investigation. One of the original goals for the study was to study the effect
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atherosclerosis on the long-term durability o f graft material, but due to the elevated
mortality this was difficult to assess using this model. However, atherosclerosis appears
to have a negative effect on long-term durability due to the increased inflammatory
response. However major modifications of this model would be required before further
studies could be done to address the role of atherosclerosis on graft durability.
Several studies could be done to further explore this phenomenon. Initially a
study would be done to eorrelate the level of cholesterol to the level of inflammation seen
in the rabbit, so a particular stage in the formation of atherosclerosis (early, intermediate
or late stage) could be targeted and then the graft could be implanted. A study could be
done in which the graft would be implanted into the abdominal aorta and upon recovery
the hypercholesterolemic diet would be started. This should demonstrate the effect of
atherosclerosis on the graft for an extended period of time. Another study would involve
inducing hypercholesterolemia in the rabbit but adjusting the diet to keep the serum
cholesterol in the clinically significant range for humans and then implanting the graft.
This would be a more relevant model to explore the effect of atherosclerosis on the graft
under similar conditions to humans.

Conclusions
Rabbits fed a normal diet survive the surgery well and the grafts remain patent for
up to 6 months. The explanted grafts are recolonized by host cells and the arrangement
o f these cells corresponds with the normal distribution of cells within a normal artery.
However, in this rabbit model the grafts elicit a chronic-type inflammatory response
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which would allow this model to be used for further study in which the inflammatory
response could be addressed by the incorporation of anti-inflammatory drugs.
Rabbits fed a cholesterol-supplemented diet had a very high incidence of post
operative mortality attributed to systemic and operative stress. Aneurysm formation was
seen in several rabbits. Hypercholesterolemia increases the presence of macrophages
within the grafts which are known to produce MMPs that degrade matrix components,
while fragments o f matrix could serve as an additional stimulus, leading to an increased
response toward the graft tissue. Based upon the histological data there seemed to be an
accelerated development of atherosclerotic lesions with the graft tissue, leading to rupture
and death in a select subset of these animals. While this model is flawed as a way to
assess the effect o f atherosclerosis on the graft material over an extended period of time,
the methodology could be re-designed to allow for longer term observations.

117

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Appendix

Table 6: Surgery and sacrifice data for all the rabbits in this study are complied in this
table. The weights at surgery and sacrifice are listed, and the cholesterol diet rabbits had
a lower operative weight compared to the normal diet rabbits, which was increased at
sacrifice . The average graft length for the normal diet group was 4.4cm and 4.5cm for
the cholesterol diet groups. The cross-clamp times did not differ significantly between the
groups (22min normal vs. 19min cholesterol).
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Table 6: Surgery and Graft Data - Diet
Rabbit
#

Surgery
Date

Normal Diet
G5588
09/17/01
G5583
09/18/01
G5581
09/19/01
G5584
09/20/01
G5587
09/20/01
G5586
09/21/01
G5830
09/25/01
G5832
09/25/01
G5831
09/27/01
09/27/01
G5828
G5825
09/28/01
G5824
09/28/01
G5827
10/03/01
G5826
N/A
Mean ± Std Dev

Cholesterol Diet
G6186
10/08/01
G6185
10/09/01
G6182
10/10/01
10/11/01
G6183
G6184
10/11/01
G6188
10/12/01
G6404
10/15/01
G6407
10/15/01
G6403
10/18/01
G6405
10/18/01
10/19/01
G6402

Weight @
Surgery

Graft
Length

X-Clamp
(min)

Graft#

Date
Opened

Sacrifice
Date

Weight @
Sacrifice

4.4kg
4.3
4.5
4
4.3
3.8
4.8
4.3
4.7
4
4.2
4.7
4.3
3.8
4.29±0.3

4.5cm
4.3
4.6
4.5
4.5
3.6
4.5
4.5
4.7
4.7
4.4
4.3
4.6
N/A
4.44±0.3

20
21
21
23
17
22
22
20
24
20
29
18
19
N/A
22±3

AP25.225
AP25.225
AP25.225
AP25.225
AP25.225
AR25.21
AR25.21
AR25.21
AR25.21
AR25.21
AR25.211
AR25.211
AR25.211
N/A

09/17/01
09/17/01
09/17/01
09/17/01
09/17/01
09/21/01
09/21/01
09/21/01
09/21/01
09/21/01
09/28/01
09/28/01
09/28/01
N/A

03/22/02
09/21/01
03/26/02
03/09/02
03/26/02
01/25/02
02/01/02
01/28/02
02/04/02
12/14/01
10/04/01
12/11/01
12/13/01
N/A

5.68kg
N/A
5.56
N/A
4.88
4.66
5.7
5.1
4.09
4.65
N/A
4.7
5.4
N/A
5.04±0.5

4.1
4.5
4.7
4.5
4.5
4.8
4.5
4.5
4.6
4.1
4.5
4.3
4.6
4
4.9
4.7
4.51±0.3

22
15
21
20
21
15
18
18
21
12
14
24
27
20
17
21
18.9±3.9

AR25.211
AR25.211
AR25.211
AR25.222
AR25.222
AR25.222
7AR25.222
2AR25.222
AR25.216
AR25.216
7AR25.216
2AR25.216
7AR25.216
7AR25.216
AP25.215
AP25.215

09/28/01
09/28/01
09/28/01
10/11/01
10/11/01
10/11/01
10/11/01
10/11/01
10/18/01
10/18/01
10/18/01
10/18/01
10/18/01
10/18/01
11/01/01
11/01/01

10/23/01*
12/21/01
12/10/01*
10/31/01*
10/14/01*
N/A
N/A
N/A
N/A
11/01/01*
10/23/01*
10/21/01*
N/A
11/05/01*
11/03/01*
11/03/01*

N/A
2.95kg
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
2.95

4
2.7
3.8
3.3
3.4
3
3.1
3.1
3
3
2.9
G6406
10/19/01
2.9
G6408
10/30/01
3
3.2
G6409
10/30/01
G6187
3.5
11/01/01
G6189
11/01/01
3.3
Mean ± Std Dev 3.15±0.3
*Found dead on the listed date
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Table 7: The sacrifice dates are listed for all rabbits, as is the duration of the graft
implantation. The causes of death are listed and rabbits were sacrificed on time,
euthanized due to complications or found dead.
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Table 7: Sacrifice - Diet
Rabbit #
Cause of Death
Normal Diet Rabbits
G5588
Sacrificed
G5581
Sacrificed
G5587
Sacrificed
G5586
Sacrificed
G5830
Sacrificed
G5832
Sacrificed
G5831
Sacrificed
G5828
Sacrificed
G5824
Sacrificed
G5827
Sacrificed
G5583
Paralysis - Euthanized
G5825
Ischemia - Euthanized
G5584
Died - Intestinal Ischemia
G5826
Spinal Injury - Euthanized
Gholestero Diet Rabbits
G6185
Sacrificed
G6182"
Hemorrhage
G6183’
Hemorrhage
G6186"
Hemorrhage
G6405"
Hemorrhage
G6409*
Hemorrhage
G6184
Surgical Hemorrhage
G6408
Surgical Complications
G6404
Spinal Injury - Euthanized
G6403
Peri-operative - Anesthesia
G6188
Peri-operative - Anesthesia
G6402
Paralysis - Euthanized
G6406
Paralysis - Euthanized
G6189
Paralysis - Euthanized
G6187
Died
G6407
Died

Duration
6 months/186 days
6 months/188 days
6 months/187 days
4 months/126 days
4 months/129 days
4 months/125 days
4 months/130 days
2 months/78 days
2 months/74 days
2 months/71 days
3 days
6 days
5+ months/170 days
N/A
73 days
46 days
20 days
15 days
14 days
6 days
3 days
1 day
N/A
N/A
N/A
4 days
2 days
2 days
2 days
1 day
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Chapter 3

The effect of a decreased inflammatory response on graft survival

Introduction
Inflammation
Inflammation has been linked to the development intimal hyperplasia
atherosclerosis

and aneurysm

’ and in all cases there is a response involving resident

and inflammatory cells, matrix metalloproteases (MMPs) and the extracellular matrix.
During an inflammatory type response there is an influx of cells into the area and
macrophages are a major component of this influx later in the response. This is
significant because macrophages have been implicated in the degradation of collagen
under normal and pathological. They are present during the development and progression
o f atherosclerosis

and in aneurysm formation

increased MMP production or activity

where their activity is due to

In vitro, binding to collagen increased the

differentiation of monocytes to macrophages and increased the release of MMP9
Based on these observations, macrophages appear to be directly involved in the
degeneration of the graft material and eventual failure leading to the hypothesis that
inflammation plays a key role in vascular graft failure.
It was hypothesized that any inflammatory response seen toward the graft
material in the previous chapter would be reduced by the administration of anti
inflammatory or anti-macrophage drugs to the rabbits. Two drugs were selected:
Indomethacin, a non-specific anti-inflammatory agent and Etidronate, a specific anti-
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macrophage agent to test this hypothesis and compared the results to a control group
treated with saline. Treatment with these drugs would allow for the determination of
whether a reduction in the overall inflammatory response (Indomethacin) would increase
graft durability or if macrophages specifically could be targeted to increase durability
(Etidronate).

Indomethacin
Indomethacin belongs to the family o f non-steroidal anti-inflammatory drugs
(NSAIDs) that include aspirin and ibuprofen, and exert their action by specifically
inhibiting the activity o f cyclooxygenase (COX). In contrast to the action of aspirin,
which irreversibly inactivates COX I and 2 via an acetylation reaction, Indomethacin
causes a slow and reversible enzyme inhibition by the formation of a salt bridge between
the carboxylate o f indomethacin and the arginine at position 120 of COX 1 and 2, located
in the hydrophobic tunnel constituting the active site of the enzyme
inhibited by acetaminophen

COX 3 is

but no mechanism is suggested.

The cyclooxygenases (COX I and 2, alternately spliced isozymes) are involved in
the production o f prostaglandins from arachidonic acid. COX I is mostly present in
platelets, is constitutively expressed, and is involved in the production of platelets,
prostaglandin Ei for kidney function, and prostaglandin I2 for mucus production in the
stomach, while COX 2 is the isoform that is induced in cells by an inflammatory
stimulus, and is involved in the production o f prostaglandin E2 (PGE2) which produces
the redness, swelling and vasodilatation in the inflammatory process

COX 3, a
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variant of COX 1, is present in brain tissue

and appears to be involved in the fever

response.
Indomethacin has been used experimentally to reduce the severity of
atherosclerosis in rabhits
rat

and to prevent elastase-induced aneurysm formation in the

In both atherosclerosis and aneurysm formation, macrophages are known to

elaborate matrix metalloproteinases (MMPs), which are involved in the degradation of
extracellular matrix components of the tissue and it is this action that is involved in the
pathology and progression o f these diseases. Indomethacin exerts an effect via inhibition
of COX 2, down-regulating PGE2 expression and in doing so, down-regulating the
production of MMP9

and attenuating aneurysm formation in an elastase-perfused

abdominal aortic rat model

Administration of indomethacin also suppressed the

formation of intimal hyperplasia in a balloon injury rat model in a COX 1-dependent
manner

Administration o f indomethacin should therefore inhibit both aneurysm

formation and anastomotic hyperplasia..

Etidronate
Bisphosphonates are very stable non-hydrolyzable analogs of pyrophosphate
characterized hy two chemically and enzymatically stable C-P bonds

This class of

drugs are used therapeutically in diseases of the hone (e.g. Osteoporosis, Paget’s disease.
Ectopic calcification. Hypercalcemia), specifically inhibiting bone resorption and
mineralization

by inhibiting the growth/hreakdown o f hydroxyapatite crystals by

binding tightly to calcium.
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Bisphosphonates can be subdivided into non-amino and amino containing
compounds which function by different mechanisms. The mode of action of non-amino
containing bisphosphonates (e.g. Clodronate and Etidronate) appears to be primarily due
to a ‘suicide’ mechanism, whereby the drugs are metabolized by macrophage-like cells
by incorporation into ATP

This produces a non-hydrolyzable ATP analog and

accumulation leads to cell death (osteoclasts and macrophages)

The remainder of

the (amino-) bisphosphonates (e.g. Pamidronate and Alendronate) inhibit isopentyl
diphosphate synthase or famesyl diphosphosphate synthase in the mevalonate pathway
which ultimately affects the prenylation of small GTP-binding proteins

inhibiting

the formation of cholesterol, and ultimately activate caspases leading to apoptosis
The effect o f bisphosphonates on macrophage function and survival is well
documented in the literature

’ ’

. These drugs are shown to accumulate in the

tissues o f both normal and atherosclerotic rabbits
as well as calcification
their anti-inflammatory effects

reduce plaque formation and severity

An unexpected collateral effect of bisphosphonates are
which could be attributed to the induction of

macrophage apoptosis.

Specific Aim: To evaluate the role of decreased infiammation via drug treatment on
the xenogenic graft material.

Rationale
Previous studies have shown that Indomethacin

and Etidronate

exert an

anti-inflammatory action in the rabbit. Both drugs also have an effect on macrophage
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activity and survival and it was hypothesized that administration of anti-inflammatory
drugs would reduce the severity o f the inflammatory response towards the Corograft™
conduit and the effect o f decreased inflammation on the vascular graft could be assessed.

Experimental Design
In this portion of the study, 3 groups of 5 rabbits were treated with saline, Indomethacin
or Etidronate prior to implantation o f the graft, and the drug treatments were continued
post-operatively. Blood samples were also collected prior to surgery and at sacrifice.
The grafts were harvested at 63 days and analyzed by histology and immunohistology.
Also, zymograms for MMP activity and a Humoral ELISA were performed on surgery
and sacrifice serum samples. As both drugs would affect macrophages, a reduction in the
number of macrophages would be used as an indicator of drug treatment efficacy. CRP
levels were to be analyzed but proved to be prohibitively expensive and were not done.
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Materials and Methods
Animal Source and Care
Female New Zealand White rabbits (weighing ~3-4kg) were purchased from
Westem Oregon Rabbit Company (Philomath, OR, USA) and allowed to acclimate for at
least 7 days before initiating any procedures. Rabbits had access to normal rabbit chow
and water ad libitum through out the duration of the study. Average room temperature
was 63°F (17-18°C), with a 12hr day/night cycle and 10-12 air changes/hr. All animals
appeared clinically normal throughout the 7 day quarantine period and no other pathogen
testing was done. Baseline blood sample was collected prior to the first injection o f drug.

Drug Administration
Each group was pretreated with drug 1-2 hours prior to surgery. This time was
chosen because previously published studies with indomethacin had shown that the
arachidonic acid cascade is initiated early on in inflammation

and in order to keep

everything equivalent the same time was used for Etidronate. Dosage: Normal Saline
(2ml SC), Indomethacin (4mg/kg SC), Etidronate (2.5mg/kg SC). Each drug was
administered once daily as described for the 63 day period of the study with weekly
adjustments for weight gain/loss. Normal saline (0.9% Sodium Chloride Irrigation, USP,
Baxter Healthcare Corporation, Deerfield, IE, USA), Indomethacin, USP (Sigma
Chemical Co., St. Louis, MO, USA) dissolved in 100% EtOH at 20mg/ml (maximum
solubility). Etidronate disodium (Didronel® I.V. Infusion, 50mg/ml, MGI Pharma, Inc.
Minnetonka, MN, USA).
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Preoperative Preparation
Rabbits were sedated with an intramuscular dose of ketamine (50mg/kg), the
abdominal region shaved, and the rabbit placed in a dorsal recumbent position on a
heating pad (heating pad was off during the hypothermic phase of the surgery).
Anesthesia was induced and maintained with 1.5-2% Isoflurane/Oxygen mixture
administered via a ventilator/anesthesia delivery system (North American Drager,
Telford, PA, USA or Isotec 4, Surgivet/Anesco Veterinary Surgical Products, Waukesha,
WI, USA), and the level of isoflurane was adjusted as needed to keep the animal
sufficiently anesthetized, as evaluated by ear pinch or any evidence of discomfort. The
chest cavity was not opened allowing for passive, spontaneous ventilation by the animal
The core temperature was monitored with a rectal temperature probe and
electrocardiographic leads were attached so the heart rate could be monitored. Icepacks
were placed around and between the hind-legs and along the lower flanks. An intra
venous cannula (22 gauge) was introduced into the marginal ear vein and cold (4°C)
supplemented Lactated Ringer’s Solution was given initiating the hypothermic phase of
the surgery. The supplemented Lactated Ringer’s solution contained per liter: 20ml
sodium bicarbonate (84mg/ml and 50mEq/50ml, American Pharmaceutical Partners, Inc.
Los Angeles, CA, USA), 50ml of 20% mannitol solution and 0.5ml dexamethasone
sodium phosphate (4mg/ml, American Regent Laboratories, Shirley, NY, USA).

Surgical Protocol
After sterile draping, a midline laparotomy was performed. The skin was
retracted with traction sutures and the intestines were displaced to the right side and
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wrapped in laparotomy sponges moistened with cold sterile saline. Isolation of the
abdominal aorta from the surrounding tissues from below the left renal artery to the iliac
bifurcation was performed meticulously to avoid accidental injury to the inferior vena
cava and its branches. Care was taken to identify all aortic branches along the entire
circumference. If feasible, anastomotic sites were planned to avoid cutting of the large
dorsal aortic branches. Once all dissection was completed, one ml of heparin was
administered i.v. (1000 USP units/ml, American Pharmaceutical Partners, Inc., Los
Angeles, CA, USA) and if necessary, further cooling of the animal was achieved by using
sterile saline slush applied directly into the abdominal cavity and to the laparotomy
sponge covering the intestines.
When the rectal temperature of the animal reached 34.5°C, the ice packs and the
saline slush were removed as the temperature continued to drop without additional
cooling. The cold supplemented Lactated Ringer’s solution was exchanged for warm
(37°C). Also, warm packs were placed next to the rabbit under the sterile draping and the
heating pad under the rabbit was switched on to start the re-warming phase of the
procedure initiating the re-warming period of the surgery.
Dorsal aortic branches within the previously prepared aortic segment were clipped
and cut. The aorta was occluded proximally and distally with micro-surgieal vascular
clamps (MORIA 200/A, Angled, 30mm. Fine Science Tools, Inc. Foster City, CA, USA)
placed below the left renal artery and above the inferior mesenteric artery. And keeping
in mind the elastic recoil of the vessel, the aorta was cut approximately 1 cm from each
clamp to avoid space issues.
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All animals had a Corograft™ (~3-4mm ID x ~4cm minimum) previously re
hydrated in heparinized saline, implanted into the infrarenal abdominal aorta. An end-toend anastomosis (distal then proximal) was performed with a continuous single 8 / 0
■Prolene suture (Polypropylene, Ethicon, Inc., Somerville, NJ, USA). Before tying the
suture for the proximal anastomosis, the distal vascular clamp was removed to flush air
firom the graft by filling the graft with blood to avoid an air embolism. After tying the
suture, the proximal vascular clamp was removed and additional 8/0 Prolene suture used
(as needed) to control anastomotic or graft bleeding.
The intestines were returned to the abdominal cavity and repeatedly lavaged with
warm sterile saline to achieve appropriate re-warming of the animal. When the rectal
temperature of the rabbit reached 36.5°C to 37.5°C, the saline was removed and the
laparotomy closed in two layers with 3/0 Vicryl (Polygalactin 910, Ethicon, Inc.,
Somerville, NJ, USA). The supplemented Lactated Ringer’s solution was discontinued,
with a total amount of 100-150ml having been administered for both the cold and warm
solutions. When the animal was re-warmed to physiological temperature (101-104°F/3840°C) and movement was seen in the hind-limbs, the animal was returned to its’ cage.
Rabbits received 0.2ml flunixin meglumine (50mg/ml, Equileve®, Phoenix
Scientific, Inc., St. Joseph, MO, USA) i.m. as an analgesic immediately after surgery, and
0.2ml i.m. flunixin meglumine BID for 4 days post-operatively. All rabbits were
monitored for neurologic or ischemic complications of the hind limbs throughout the
study. No antibiotic prophylaxis, platelet aggregation inhibitors nor anticoagulants were
used postoperatively.
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For rabbits in the drug treatment groups, the flunixin dosage (50mg/ml,
Equileve®, Phoenix Scientific, Inc., St. Joseph, MO, USA) was adjusted to 1.1 mg/kg
postoperatively and then 1.1 mg/kg BID for the following 3 days.

Sacrifice
The animals were sedated, brought to a full surgical plane of anesthesia, and
sacrificed before graft isolation. The abdominal incision was re-opened and the graft
dissected from surrounding tissues. The graft was then excised en-bloc and placed into
Histo-Choice Tissue Fixative MB (Amresco Inc., Solon, Ohio, USA) for a minimum of
24hrs before further processing.

Macroscopic Examination
Excess non-adherent tissue/fat was trimmed from the exterior of the graft and the
graft was photographed with markers placed indicating the suture lines and direction of
flow. Each graft was evaluated macroscopically for aneurysmatic changes (indicated by
an area of vessel wall ballooning outwards and being of a greater diameter than the
originally implanted graft), atherosclerotic lesions, thrombus, or any other obvious
abnormalities.

Histology
Samples (2-3mm) cut from the center o f the graft were dehydrated and embedded
in PolyFin wax (Polysciences, Inc., Warrington, Pennsylvania, USA), sectioned at 5pm,
and collected on slides coated with poly-L-lysine (Sigma Chemical Co., St. Louis, MO,
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USA) or charged slides (Superfrost® plus, VWR Scientific, West Chester, PA, USA).
Representative sections were stained with hematoxylin and eosin (H&E) for general
tissue/cellular morphology, Masson’s Trichrome for collagen and Movat’s Pentachrome
stain for collagen and elastin

Immunohistology
Slides for immunohistology were prepared as above. Representative sections
were stained for a-smooth muscle cell actin (a smooth muscle cell/myofibroblast
marker), CD3 (pan-T cell antibody) and RAM 11 (rabbit macrophage-specific antibody).
Sections stained for a-SMC actin were deparaffinized, treated with 3% H 2O2 for 5min to
remove endogenous peroxidases, rinsed with dH2 0 and blocked with 0.05% Tween-20
(Sigma Chemical Co., St. Louis, Missouri, USA) in phosphate buffered saline (PBS-T)
for 30min. The slides were incubated for 30min with the appropriate primary antibody
diluted in PBS-T, then rinsed with PBS-T. Sections stained for a-actin were incubated
with Protein A-horseradish peroxidase (Sigma Chemical Co., St. Louis, Missouri, USA),
1:500 dilution in PBS-T for 30min. Sections stained for rabbit macrophages (RAM 11)
and T cells (CD3) were treated with the components of the LSAB-2 biotin-streptavidin
amplification kit (DAKO, Carpinteria, California, USA) according to the supplied
instructions with the incorporation o f an avidin/biotin blocking procedure. All
incubations were carried out in a moist chamber at room temperature. Sections were
rinsed with PBS-T and developed by the addition of lOOpl of DAB substrate (Sigma Fast
DAB, Sigma Chemical Co., St. Louis, Missouri, USA) per slide. The development was
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stopped with water and the slides counterstained with H&E or hematoxylin alone. The
slides were dehydrated, cleared and coverslipped.
Antibody to:
a-Smooth Muscle Cell Actin
Rabbit Macrophage
T Cell/CD3

Clone
1A4
RAM 11
Rbt poly

Dilution
1:400
1:500
1:50

Development
Protein A-HRP
LSAB-2
LSAB-2

Source
Sigma
Dako
Dako

Macrophage Counts
Macrophages are involved in the inflammatory response toward the graft, and the
numbers present were used as an indirect indicator o f disease severity or efficacy o f drug
treatment. Slides stained with the RAMI 1 antibody were used in this portion of the
study. Five random lOOX fields were photographed at the junction between graft tissue
and ablumenal tissue where the majority o f the chronic-type inflammatory reaction was
located. The images were imported into Corel Photo-Paint, gamma adjusted to sharpen
the color, and counted manually. The number of single macrophages and giant cells were
counted per image and averaged to obtain the count.

Zymography
MMPs are produced as part of an inflammatory response and are involved in graft
degeneration, therefore pre- and post-operative serum samples were qualitatively
evaluated for circulating MMP levels. The conditions present during zymography allow
for the detection o f both the pro-forms and activated MMPs, due to the dissociation o f the
active MMPs from inhibitors or the spontaneous activation of zymogens
Serum samples were electrophoresed on 10% polyacrylamide gels containing
1mg/ml Gelatin or Elastin. The samples were diluted 1:10 (v:v) with saline and then 1:1
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with 2X Non-denaturing Sample Buffer (no P-Mercaptoethanol), 20pl loaded onto the
gel and run at 200 V until completion. The gels were washed 2X 30 min with 2.5%
Triton X - 1 0 0 /dH 2 0 with agitation, washed 30 min with RT Activation Buffer with
agitation, and then incubated 0/N in Activation Buffer at 37°C with agitation
(Activation buffer 25mM Tris, lOmM CaC^, IpM ZnCb, 50mM NaCl, pH 7.5). Gels
were stained with coomassie brilliant blue and areas of gelatinolytic or elastolytic activity
were seen as clear bands against a blue background. MMP activity was confirmed by
incubating the gels in the presence o f Immol/L 1,10-phenantroline (MMP inhibitor) in
the activation buffer in both the 30 minute wash and ovemight incubation
The MMP profile for all groups did not change between the surgery and sacrifice
samples within groups, between groups, or between normal diet and cholesterol diet.
Also, no major observable differences in band intensity were seen between surgery and
sacrifice samples by visual examination.

ELISA for Humoral Response
Dry graft material was lyophilized to a constant weight, suspended in 1% acetic
acid at a concentration of 1mg/ml (w/v) and homogenized. The material was diluted to
~250ug/ml with 0.02M Carbonate buffer (pH 9.6) and lOOul (~25ug/well) of collagen
was added to each well of a 96-well plate (Falcon PRO-BIND™, Becton Dickinson and
Company, Franklin Lakes, NJ, USA). The plates were evaporated to dryness ovemight at
room temperature in a hood. Before use, the plates were washed 4X with PBS-T and
blocked for 45 min RT (or O/N at 4°C) with lOOul PBS-T/1% BSA per well. The wells
were then rinsed 4X with PBS-T and serial 2-fold dilutions of serum were plated in
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PBS/1 % BSA (50ul/well in duplicate). The plates were incubated at RT for Ihr and
washed 4X with PBS-T. Anti-Rabbit IgG-HRP (Monoclonal Anti-Rabbit IgG y-chain
specific, Clone RG-96, Peroxidase Conjugate A -1949, Sigma-Aldrich Co, St Louis, MO,
USA) was diluted 1;40,000 in PBS-T/1% BSA and 50ul/well was added. The plate was
incubated 2hrs at RT and washed 4X with PBS-T. OPD substrate (HRP substrate, Dako
Corporation, Carpinteria, CA, USA) was prepared according to the manufacturers
instructions (dissolved in room temperature dHaO and 30% H2 O2 added) and 50ul of the
substrate solution was added to each well. The color was allowed to develop 30min at
room temperature and the reaction stopped by the addition of 50ul of 0.5M H2 SO4 to each
well. The absorbance was read at 490nm in a microplate reader (Opsys MR, Dynex
Technologies, Chantilly, VA, USA).
Normal rabbit serum was included as the negative control and the values obtained
used to adjust for serum absorbance. In all cases the CD value from the normal rabbit
serum was subtracted from the mean valued obtained for the corresponding dilutions of
the experimental samples. The titer listed is derived from the last well giving a positive
OD after adjustment. Blank values were obtained from wells incubated with PBS-T/1%
BSA instead o f serum and subtracted from all OD values by the microplate reader
software.
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Results
Post-operative survival
Tw enty-ei^t rabbits were implanted with a graft during this portion of the study.
Fifteen rabbits made up the three experimental groups, which were treated with Saline,
Indomethacin or Etidronate. The remaining 13 rabbits were excluded due to
complications. Four rabbits died during surgery of unknown causes after unclamping the
abdominal aorta. Four were found dead in their cages on day 0 post-operatively, 3 of
unknown causes and 1 due to operative complications. Two developed paralysis during
the post-operative recovery period and were euthanized on day 0. Three additional
rabbits survived the surgery but developed complications unrelated to the graft and were
later euthanized. In all cases the implanted grafts were patent upon necropsy.

Drug Treated Groups Macroscopic
No obvious differences were noted between groups. All grafts were patent at explant and
were surrounded by host tissue with little to no adhesions seen within the abdominal
cavity. No obvious degeneration or aneurysmic dilation of graft material was seen
(Figures 10,11 & 12: Saline, Indomethacin & Etidronate Macroscopic).

Histology
Saline Controls 2 Months (Figure 13: Saline Control Histology)
In samples H8542 and H8538, the graft matrix was present in two distinct layers, medial
more lumenal and adventitial, and some adherent clot was seen in the lumen (post
mortem). The graft tissue was relatively aeellular with well-preserved matrix although
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Figure 10: Macroscopic images of Saline treated control samples. Grafts are shown in
both an external (Panel A, C, E, G, and I) and internal view (Panel B, D, F, H and J). All
grafts were patent at explant and were surrounded by host tissue. No dilation was seen in
any of the samples. The coagulated blood seen in the lumen of Grafts H8542, H8538 and
H8540 is from post-mortem clotting, tA rrow s indicate the suture lines. In all cases, the
flow of blood is firom left to right.
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Figure 10: Saline sample macroscopic
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Figure 11: Macroscopic images of Indomethacin treated samples. Grafts are shown in
both an extemal (Panel A, C, E, G, and I) and internal view (Panel B, D, F, H and J). All
grafts were patent at explant and were surrounded by host tissue. No dilation was seen in
any of the samples. The coagulated blood seen in the lumen of Grafts H8790 and H8707
is from post-mortem clotting, tArrows indicate the suture lines. In all cases, the flow of
blood is from left to right.
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Figure 11: Indomethacin treated macroscopic
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Figure 12: Macroscopic images of Etidronate treated samples. Grafts are shown in both
an extemal (Panel A, C, E, G, and I) and internal view (Panel B, D, F, H and J). All
grafts were patent at explant and were surrounded by host tissue. No dilation was seen in
any of the samples. The coagulated blood seen in the lumen of Grafts H8790 and H8707
is firom post-mortem clotting, tArrows indicate the suture lines. In all cases, the flow of
blood is from left to right.
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Figure 12; Etidronate treated macroscopic
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cells were present within the medial (circumferential) layer (WBCs). In samples H8541,
H8536, and H8540 the graft matrix was very cellular, and the layers were not clearly
defined due to expansion o f the graft material by cells and new matrix material. Grafts
H8542 and H8538 had a thin ablumenal layer containing mostly loose connective tissue,
blood vessels and other cells of unknown type. Grafts H8541, H8536, and H8540 had a
relatively thick ablumenal layer containing blood vessels, adipose tissue as well as
immature collagen fibrils and collections of inflammatory-type cells (Fig. 13-lA and C).
No actin staining seen within grafts H8542 and H8538, though ablumenal blood vessels
were staining. In grafts H8541 and H8536 cells staining for a-SMC actin were present
for ~ 1/2 of the circumference in both the medial layer and adventitial (longitudinal) layer
(Fig. 13-2A, C and D), and in ablumenal blood vessels. A few cells staining for actin
were present in the more superficial medial layer of graft H8540 although blood vessels
were stained. Macrophages and giant cells were located at the junction between the
adventitial (longitudinal) layer and the thin ablumenal layer of H8542 and H8538. A
layer of giant cells separated the medial and adventitial matrix, and formed a ring around
the graft tissue of H8541 (Fig. 13-lD), and giant cells were also seen within the medial
layer. Occasional giant cells were also seen adherent to the lumenal surface, and in some
cases were located in the more superficial portion of the medial layer and caused a
portion of the graft material to protrude into the lumen. In H8536 and H8540 few giant
cells were present, mostly located between the medial and the adventitial layers of the
graft as well as within the ablumenal layer, while single macrophages were present within
the adventitial tissue. Trichrome staining of H8542 and H8538 showed the majority o f
the collagen was mature and well-preserved (Fig. 13-3B and E). Trichrome of H8541,
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H8536, and H8540 showed that the majority of the collagen present was stained more
lightly although remnants of more darkly stained mature collagen fibers were still present
in the adventitial layer (Fig. 13-3A, C and D), and the ablumenal layer contained a loose
collection of small, lightly stained collagen fibrils. Movats staining of H8542 and H8538
showed well-preserved elastin in the adventitial (longitudinal) layer, elastic fibrils in the
medial (circumferential layer), and a complete internal elastic lamina. In H8541 and
H8536, elastin fibers were not readily apparent and no internal elastic lamina remained.
In H8540 elastin fibers were present within the medial (circumferential) layer but no
internal elastic lamina remained. All samples had cells staining for CD3 scattered
throughout the ablumenal layer.

Indomethacin Treated 2 Months (Figure 14: Indomethacin Histology)
Samples from H8535, H8794 and H8792 showed the graft matrix was present in two
distinct layers, medial and adventitial with some adherent clot present within the lumen
(post-mortem). The graft tissue was relatively acellular with well-preserved matrix
although cells were present within the medial layer and appeared to be mostly PMNs
(Fig. 14-1 A, C and D). The graft matrix of H8790 and H8797 was present in two
distinct layers with some adherent lumenal clot. In these cases, two-thirds of the graft
tissue was relatively acellular with well-preserved matrix with PMNs within the medial
layer (Fig. 14-lB and E), while the remaining third of the graft was re-colonized by hostderived cells. Sample H8790 also had PMNs adherent to the lumenal surface. The
ablumenal layer o f samples H8535, H8794, H8790 and H8797 was thin and contained
mostly loose connective tissue, blood vessels and some other cells of unknown type.
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Figure 13-1; Saline control samples were embedded and 5pm sections were stained with
H&E for general tissue morphology and cellularity. The graft tissue in H8538 and
H8542 was relatively acellular with well-preserved matrix while in H8536, H8540 and
H8541 the graft matrix was very cellular. Collections of inflammatory-type cells were
seen in H8536 and H8540 (open circles). Macrophages and giant cells in H8541 formed
a ring around the graft tissue and were seen within the medial layer (|). In H8536 and
H8540 few giant cells were present. Scale bar ~100pm.
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Figure 13-1: FI&E stain o f Saline control samples
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Figure 13-2: Saline control samples were embedded and 5pm sections were stained for asmooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The
presence of actin-staining cells would indicate the presence of host-derived
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in
blood vessels). No actin staining was seen within H8542 and H8538, in H8541 and
H8536 cells staining for a-SMC actin were present in both the medial layer and
adventitial layer, and in G8540 a few cells staining for actin were present in the medial
layer (open circles). Scale bar ~ 100pm.
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Figure 13-2: Actin stain of Saline control samples
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Figure 13-3: Saline control samples were embedded and 5pm sections were stained by
Massons Trichrome. This stain is for collagen integrity and organization. The darker
blue collagen is considered more mature, while lighter staining collagen is considered
indicative of less mature collagen. The majority of the collagen was mature and wellpreserved in H8538 and H8542 while in H8536, H8540 and H8541 the majority of the
collagen present was more lightly stained with remnants of more darkly stained mature
collagen fibers in the adventitial layer (open circles). Scale bar -lOOpm.
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Figure 13-3: Trichrome stain of Saline control samples
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while graft H8792 had a relatively thicker ablumenal layer containing blood vessels,
adipose tissue, collagen, few inflammatory-type cells and some macrophages and giant
cells. In all grafts (H8535, H8794, H8790, H8797, and H8792), macrophages and giant
cells were located at the junction between the adventitial layer of graft tissue and the
ablumenal layer (Fig 14-lA to E). In H8790 macrophages and giant cells were seen
adhering to a portion of the lumen directly apposed to the internal elastic lamina. Actin
staining was mostly confined to adventitial blood vessels in all samples. In addition to
blood vessels, H8794 had a few actin staining cells within the graft at the Junction
between the medial and adventitial layer, and in H8790 several actin staining cells were
seen within the adventitial layer o f the graft (Fig.l4-2B and D). Trichrome showed the
majority of the collagen was mature and well-preserved in H8535, H8790, H8797 and
H8792 (Fig 14-3A, B, C and E). In H8790, H8797 and H8792 the medial layer appeared
expanded, and mature collagen and looser cormective tissue was seen in the ablumenal
layer. Trichrome of H8794 showed the majority of the collagen was newer, though
mature collagen was present and may be a remnant from the original graft (Fig, 14-3D).
Movats showed well-preserved elastin in the adventitial layer, fibrils in the medial layer,
and a complete internal elastic lamina in H8535, H8797, H8792, while a mostly complete
internal elastic lamina was seen in H8794 and H8790. Cells staining for CD3 were
scattered throughout the ablumenal layer in all samples.

Etidronate Treated 1 Month* (Figure 15: Etidronate Histology)
The graft matrix from rabbit H9085 was present in two distinct layers, medial and
adventitial. The graft tissue was relatively acellular with well-preserved collagen.
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Figure 14-1: Indomethacin samples were embedded and 5pm sections were stained with
H&E for general tissue morphology and cellularity. H8535, H8794 and H8792 showed
the graft tissue was relatively acellular with well-preserved matrix although cells were
present within the medial layer and appeared to be mostly PMNs (open circles). In
H8790 and H8797 the majority of the graft tissue was relatively acellular with wellpreserved matrix with PMNs within the medial layer. Sample H8790 also had PMNs
adherent to the lumenal surface (i). In H8535, H8794, H8790, H8797, and H8792
macrophages and giant cells were located at the junction between the adventitial layer of
graft tissue and the ablumenal layer (t). Scale bar ~ 100pm.
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Figure 14-1: H& E stain o f Indomethacin samples
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Figure 14-2: Indomethacin samples were embedded and 5pm sections were stained for asmooth muscle cell actin, a marker of smooth muscle cells and myofibroblasts. The
presence of actin-staining cells would indicate the presence of host-derived
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in
blood vessels). Actin staining was mostly confined to adventitial blood vessels in all
samples. H8794 had a few actin staining cells within the graft at the junction between the
medial and adventitial layer, and in H8790 several actin staining cells were seen within
the adventitial layer of the graft (t). Scale bar ~100pm.
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Figure 14-2: Actin stain of Indomethacin samples
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Figure 14-3: Indomethacin samples were embedded and 5pm sections were stained by
Massons Trichrome. This stain is for collagen integrity and organization. The darker
blue collagen is considered more mature, while lighter staining collagen is considered
indicative o f less mature collagen. In H8535, H8790, H8797 and H8792 the majority of
the collagen was mature and well-preserved. In H8790, H8797 and H8792 the medial
layer appeared expanded (open circles) while in H8794 the majority of the collagen was
newer (open circle), though mature collagen was present and may be a remnant from the
original graft (|). Scale bar -lOOpm.
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Figure 14-3: Trichrome stain of Indomethacin samples
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although cells were present within the medial layer and appeared to be mostly PMNs
(Fig. 15-lC). A relatively thicker ablumenal layer was present containing blood vessels,
adipose tissue, collagen, numerous inflammatory-type cells and numerous macrophages
and many giant cells that were located at the junction between the adventitial layer of
graft tissue and the ablumenal layer as well as within this layer (Fig. 15-lC). No actin
staining cells were seen within the adventitial layer of the graft, and adventitial blood
vessels were staining (Fig. 15-2C). Trichrome showed that the medial layer appeared
expanded, mature collagen and looser connective tissue were seen in the adventitial layer
and ablumenal layers. Movats showed well-preserved elastin in a majority of the
adventitial layer, fibrils in the medial layer, and a complete internal elastic lamina.
Occasional cells staining for CD3 were scattered throughout the ablumenal layer.

Etidronate Treated 2 Months (Figure 15: Etidronate Histology)
The graft matrix of H9086, H9087 and H9084 was present in two distinct layers, medial
and adventitial. The graft tissue was relatively cellular with well-preserved collagen, and
the cells present within the medial layer appear to be mostly PMNs in H9086, mostly
PMNs and macrophages with a few fibroblastic-type cells in H9087, while in H9084
were PMNs, macrophages with the majority of this layer repopulated with fibroblastic
type cells (Fig. 15-lB, D and E). In H9081 the graft matrix was present in two distinct
layers, medial and adventitial but was relatively acellular with well-preserved matrix
although cells are present within the medial layer and appear to be mostly PMNs (Fig.
15-lA). All samples had an ablumenal layer of varying thickness containing blood
vessels, adipose tissue, collagen, few inflammatory-type cells and macrophages (Fig. 15-
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lA , B, D and E). In H9086 and H9087 few macrophages and giant cells were located at
the junction between the adventitial layer o f graft tissue and the ablumenal layer, and
H9087 had more giant cells present within the ablumenal layer. Sample H9084 had
many giant cells and single macrophages located at the junction of the adventitial and
ablumenal layer, with more giant cells present within the ablumenal layer (Fig. 15-lB).
H9081 had few macrophages and many giant cells giant cells at the junction of the
adventitial and ablumenal layer as well as deeper in this tissue layer. Macrophage giant
cells were also seen adherent to the lumenal surface (Fig. 15-3A). In addition to actin
staining seen in the ablumenal tissue of all samples, H9086 had several actin staining
cells sparsely distributed within the adventitial layer of the graft (Fig. 15-2D). H9087
had numerous actin staining cells distributed within the medial and adventitial layer of
the graft and in the ablumenal tissue (Fig. 15-2E). H9084 had several small collections
of actin staining cells that were distributed within the medial and adventitial layers and a
larger patch present on the lumenal surface of the graft (Fig. 15-2B). Although not a
complete re-population, actin staining cells were seen within the medial layer at the
junction with the adventitial layer of the graft and in the adventitia of H9081 (Fig. 152A). In all samples, trichrome staining showed the majority of the collagen was mature
and well-preserved, the medial layer appeared expanded, and mature collagen and looser
connective tissue were seen in the ablumenal layer (Fig. 15-3A to E ) . Movats showed
well-preserved elastin in a majority of the adventitial (longitudinal) layer, fibrils in the
medial (circumferential) layer, with a complete intemal elastic lamina in H9086, or an
occasional fragment o f intemal elastic lamina in H9087. In H9084 and H9081, Movats
showed well-preserved elastin in a majority of the adventitial layer, few fibrils in the
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medial (circumferential) layer, and no intemal elastic lamina (H9084) or a fragmented
intemal elastic lamina (H9081). Occasional cells staining for CD3 were scattered
throughout the ablumenal layer.

Macrophage Counts
The saline control group had a mean of 44.8 macrophages present, while this number was
reduced for the dmg-treated groups. The Indomethacin group had a mean of 14.68
macrophages, and the Etidronate group had a mean of 13.5 macrophages (without 9085
25 day) and 20.3 macrophages per lOOX field (with 9085). This corresponds to a 67.2%
reduction in mean number of macrophages present in the Indomethacin samples, and a
69.95% reduction in mean number of macrophages in the Etidronate group (no 9085).
The differences between the saline controls and the dmg treatment samples are
statistically significant by Dunnett multiple comparison tests (Indomethacin P<0.01,
Etidronate P<0.05)

Zymography
The MMP profiles did not change between the surgery and sacrifice samples and no
major observable differences in band intensity were seen between surgery and sacrifice.
However, zymograms showed a difference in the MMP profile between control and drug
treated samples, seen as an absence o f the higher mw MMPs and several minor bands in
both the Indomethacin and Etidronate groups. The Etidronate serum samples showed
nearly a complete absence of MMP activity, while the activity was very reduced in the
Indomethacin samples. Development in the presence of 1,10-phenanthroIine (MMP
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Figure 15-1: Etidronate samples were embedded and 5pm sections were stained with
H&E for general tissue morphology and cellularity. H9085 was relatively acellular with
well-preserved collagen, although cells were present within the medial layer and
appeared to be mostly PMNs (open circle). Numerous inflammatory-type cells (t),
macrophages and giant cells (J.) were located at the junction between the adventitial layer
o f graft tissue and the ablumenal layer and within this layer. H9086, H9087 and H9084
was relatively cellular with well-preserved collagen, and the cells present within the
medial layer appear to be mostly PMNs in H9086, PMNs and macrophages with a few
fibroblastic-type cells in H9087, H9084 were PMNs, macrophages and fibroblastic type
cells (open circle). H9081 the graft matrix was relatively acellular with well-preserved
matrix although the cells present within the medial layer appear to be PMNs (open
circles). H9086 and H9087 few macrophages and giant cells were located at the junction
between the graft tissue and the ablumenal layer, and H9087 had more giant cells present
within the ablumenal layer. H9084 had many giant cells and single macrophages located
at the junction o f the graft and ablumenal layer. H9081 had few macrophages and many
giant cells giant cells at the junction of the graft and ablumenal layer with macrophage
giant cells adherent to the lumenal surface. Fewer inflammatory-type cells (t) were
present in H9081, H9086, H9087 and H9084 compared to H9085. Scale bar -lOOpm.
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Figure 15-1: FI&E stain o f Etidronate samples
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Figure 15-2: Etidronate samples were embedded and 5pm sections were stained for asmooth muscle cell actin, a marker o f smooth muscle cells and myofibroblasts. The
presence of actin-staining cells would indicate the presence of host-derived
myofibroblasts (involved in healing) or smooth muscle cells (cells normally present in
blood vessels). In H9085 no actin staining was seen within the graft. H9086 had several
actin staining cells sparsely distributed within the adventitial layer o f the graft. H9087
had numerous actin staining cells distributed within the medial and adventitial layers of
the graft. H9084 had several small collections of actin staining cells within the medial
and adventitia layers with a larger patch present on the lumenal surface (f). Actin
staining cells were seen within the medial layer at the junction with the adventitial layer
of the graft of H9081. Scale bar ~100pm.
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Figure 15-2; Actin stain of Etidronate samples
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Figure 15-3: Etidronate samples were embedded and 5pm sections were stained by
Massons Trichrome. This stain is for collagen integrity and organization. The darker
blue collagen is considered more mature, while lighter staining collagen is considered
indicative of less mature collagen. In all samples. Trichrome staining showed the
majority o f the collagen was mature and well-preserved with newer collagen present
(open circles). Scale bar ~100pm.
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Figure 15-3: Trichrome stain of Etidronate samples
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inhibitor) indicated that the majority of the gelatinolytic activity was due to MMPs, with
very little due to other proteases (data not shown). No elastolytic activity was observed
in any of the samples at 4 days.

Humoral ELISA
Statistical analysis o f the ELISA titer log values indicated that there were no significant
differences between surgery and sacrifice in the saline treated groups (paired two-tail T
test). Statistically significant differences (paired two-tailed T test) were seen between the
surgery and sacrifice samples for Indomethacin (P<0.0001) and Etidronate (P = 0.0054).
However no significant differences were seen between the control and drug-treated
samples at sacrifice.
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Table 8: Macrophage counts from Drug treatment samples.
Slides stained for RAMI 1 were used to generate the counts. Five high-power fields were
photographed at the junction of the graft material and the ablumenal host tissue. The
macrophages were counted, and the number averaged to obtain the given values. Values
are Mean ± SEM.
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Table 8: Macrophage Counts - Drug Treatment
Rabbit #

Average # of
Macrophages

Mean # of
Macrophages^

Control
H8541 2 month
56.2
H8542 2 month
40.2
H8538 2 month
44.8±6.4
46.8
H8536 2 month
22.8
H8540 2 month
57.8
Indomethacin
H8535 2 month
16.8
H8794 2 month
18.8
H8790 2 month
10.6
14.6+2.6
H8797 2 month
20.6
H8792 2 month
6.6
Etidronate
H9085* 1 month
12.6
H9086 2 month
47.4
H9087 2 month
13.8
22.15+8.6
H9084 2 month
18.0
(20.3±6.9*)
H9081 2 month
9.4
Indicates numbers calculated with the 1 month sample

% Reduction in
# Macrophage

N/A

67.2%

50.5%
(54.6%*)

"Mean ± SEM
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Figure 16: To analyze differences in MMP presence or expression between surgery and
sacrifice samples, equivalent amounts o f serum were electrophoresed on 10% acrylamide
gels containing 1% gelatin. The gels were run to completion, washed to remove SDS,
and incubated in activation buffer (with and without MMP inhibitor) for the appropriate
time. Gels were stained with coomassie brilliant blue, and active bands appear as clear
bands on a blue background. No observable differences were seen within or between
groups, or between diet types for all rabbits.
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Figure 16: Zymograms o f Normal, Indomethacin and Etidronate samples
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Table 9; Serum samples were eollected and stored at -60°C until all had been collected
then the humoral response toward the graft material was quantified by the humoral
ELISA. Each sample was analyzed in duplicate, with each plate containing an internal
blank. All readings were averaged, adjusted for normal rabbit serum OD, and the
reciprocal given.
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Table 9: ELISA - Drag Treatment
Titer @
Surgery
Saline controls
8541
160
8542
2560
640
8538
320
8536
8540
80
Indomethacin treated
8535
20
8792
20
8790
40
8797
40
8794
80
Etidronate treated
9086
20
9087
20
9084
20
9085*
20
9081
20
Rabbit #

Titer @
Sacrifice
1280
320
160
2560
2560
320
320
320
320
320
80
10240
2560
2560
2560
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Figure 17: The log o f the ELISA titers were plotted to graphically show the differences
between the humoral response to the graft material at surgery and then at sacrifice. In all
cases except 2 (saline H8542 and H8538), there was an increased humoral response to the
graft between surgery and sacrifice. Statistically significant differences (paired twotailed T test) were seen between the surgery and sacrifice samples for Indomethacin
(P<0.0001) and Etidronate (P = 0.0054). However no significant differences were seen
between the control and drug-treated samples at sacrifiee.
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Figure 17: ELISA of Control, Indomethacin and Etidronate Samples
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Table 10: Compiled Results of Saline, Indomethacin and Etidronate treated samples. The
histology, immunohistology, macrophage counts, and ELISA information are
summarized to provide an overview o f the results.
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Table 10: Compiled Results o f Drug Treatment Samples
Animal #

Graft
Cellularity

Saline control
++++
H8536
+
H8538
+
H8540
+++
H8541
H8542
Indomethacin treated
H8535
H8790
-/+
H8792
H8794
-/+
++
H8797
Etidronate treated
+
H9081
++
H9084
H9085
-/+
+
H9086
+++
H9087

Actin

Collagen
Remodel

Macrophage
Presence

Tissue
Destruction

Humoral
Response

++++
+
+++
-

+++
+
+
++++
+

+++
+++
++
++
+

+
-

+++
+
+++
++

-/+
-/+
+
-

-/+
-/+
+
+++
++

+
+
+
+
+

-

++
++
++
++
++

++
+
+
+++

++
+
+
+
++

++
+
+
+
+

-

+++
+++
+++
+/++++

+++

Graft Cellularity -(0%) —^ ++++ (100%) re-colonization of graft material by host cells.
Actin -(0%) —> ++++ (100%) recolonization of graft media by actin-positive cells.
Collagen Remodel -(0%) —> ++++ (100%) newly produced collagen vs. mature.
Macrophage Presence -(few macrophages) —> ++++ (40-50) avg. # macrophages.
Tissue Destruction -(0%)

++++ (100%) destruction of original graft material.

Humoral Response -(0%)

++++ (100%) of maximum response, rated relative to the

highest response seen for all grafts.
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Discussion
Reduce Inflammation: Effect of Anti-Inflammatory Drugs
Observations from the previous portion of the study suggest that these rabbits
developed a chronic inflammatory-type response toward the graft material. A common
finding in the previous chapter was the constant presence of macrophages and giant cells
in the ablumenal tissue, suggesting a chronic-type inflammatory reaction. This led to the
use of this model o f grafting to evaluate additional treatment strategies to enhance the
durability o f graft material in vivo. As macrophages are important players in
inflammation and have been implicated in graft degeneration, the drugs chosen for this
portion o f the study had previously been shown in published studies to reduce
macrophages in rabbit models of atherosclerosis, and it was speculated that they might
also improve the durability of the grafts in this study.
Macroscopically, none of the grafts in the 3 groups showed any evidence of
aneurysm or dilation which is in direct contrast to samples fi-om chapter 2. In the
previous chapter, little dilation was seen at 2 months and was increased at 4 months,
while in this portion of the study two months may be insufficient for graft dilation to
occur. In nearly ever graft in this study, the graft matrix was either well-preserved or had
undergone some remodeling, implying that little collagen degeneration had occurred
compared to the 2 ,4 and

6

month samples in which more collagen remodeling had

occurred. This may be due to differences in the physiology of the animals between the
two studies or differences in the graft material. Further studies to explore these
differences could include longer studies incorporating these drugs to evaluate the drug
effects on the development of dilation, as well as correlating changes in graft matrix
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degeneration with dilation or aneurysm development by quantifying the collagen and
elastin content of the graft.

Indomethacin
Rabbits were treated with indomethacin prior to and after graft implantation and
on explant at 2 months the grafts were found to be incorporated into the host. The grafts
were covered with host-derived tissue with little evidence fibrosis. Microscopic analysis
of the samples showed the graft material was minimally re-colonized by host-derived
cells when compared to controls. The rabbits treated with Indomethacin showed a
marked decrease in the number of macrophages present with the graft tissue compared to
the saline controls with no incidence of graft degeneration.
Published studies suggest that the reduction in the number o f macrophages could
be due to the effect of Indomethacin on the arachidonic acid cascade activated during
inflammation. Indomethacin inhibits the initial phospholipase cleavage of membrane
phospholipids to arachidonic acid

reducing the response, and also acts further down the

cascade by directly activating peroxisome proliferator-activated receptors (PP AR) a and
Y

which are down-regulated by LTB4 and PGJ2 respectively during inflammation. This

activation results in the apoptosis of activated (PPARa) and un-activated (PPARa and y)
macrophages

The use of PPAR agonists would allow for this mechanism to be

explored, allowing for the inhibition o f macrophages without affecting the remainder of
the inflammatory response, and evaluating the effect on graft durability.
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Etidronate
The grafts recovered at 2 months treated with Etidronate before and after surgery
also were found to be incorporated into the host. The grafts were covered with hostderived tissue with little evidence fibrosis. Microscopic analysis of the samples showed
the graft material was re-colonized by host-derived cells to a greater extent that
Indomethacin treated samples. The rabbits treated with Etidronate also showed a marked
decrease in the number o f macrophages present with the graft tissue compared to the
saline controls with no incidence of graft degeneration. Published studies suggest this
reduction may be due to the induction of apoptosis in these cells by the drug

This

mechanism could be further explored by the use of statins in grafted animals, which
should also reduce macrophages.

Zymography
No reduction in circulating serum MMPs was seen within groups when
Indomethacin or Etidronate treated samples from surgery and sacrifice were compared.
This may be due to the methodology which may not be sensitive enough to detect the
differences. Another possibility could be that since the graft is a small part of the
vasculature and the MMPs secreted within the area of the graft are diluted in the blood
stream the differences can not be detected. However, in-depth analysis of the graft
samples for MMPs with more sensitive techniques such as immunohistology or western
blotting could reveal differences not seen with zymography.
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Humoral response
No significant differences were seen in the humoral response between controls
and drug treated samples at sacrifice. In all cases the response was increased suggesting
the graft material elicits a response and this may be due to eomponents of the xenogenic
extracellular matrix (such as collagen) stimulating a response. Extracellular matrix
components are known to elicit an immune response

and the macrophages and giant

cells may be presenting graft antigens to T and B cells resulting in the immune response
toward the graft material.
However what we are seeing is a snap-shot at a single time-point and does not
indicate what the response has been previously or will be in the future. A better way to
monitor the humoral response would be to collect multiple samples throughout the
duration o f the study and to follow the trend of the response. This would more accurately
show what is happening over time.

Conclusions
No aneurysm development was seen in any of the drug study samples (controls
and treated) but 2 months may not be enough time to develop aneurysm under
normocholesterolemic conditions. Both Indomethacin and Etidronate reduced the overall
macrophage number present when compared to saline controls, but since macrophages,
giant cells and T-cells are still present this suggests that there is still and ongoing
response. No statistically significant difference was seen in the humoral response in any
of the groups and the zymography data was inconclusive.
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Taken together these data suggest that anti-inflammatory treatments affect the
host response toward the graft material by reducing the presence of macrophages, but
other mechanism could also be responsible. Also, this suggests that the use o f adjunct
anti-inflammatory treatments after bypass grafting could improve the long-term
durability and survival of grafts in the clinical setting by reducing cells involved in graft
failure. These data could also lead to further modifications of the original graft material
during production, leading to a product with superior resistance to inflammatory
degradation. However, care must be taken not to suppress the inflammatory response
excessively, as this could lead to detrimental effects on the normal healing process.
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Appendix

Figure 18: This figure illustrates the effects of indomethacin on inflammation as well as
the possible mechanisms by which inflammation, macrophages and MMPs are regulated.
Generated from references 25.26,28,52,58-65
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Figure 18: Indomethacin Effects on Inflammation
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Figure 19: The effects of both bisphosphonate and amino-bisphosphonates on cell
survival are illustrated. Amino-bisphosphonates act via inhibition of mevalonate
pathway, while bisphosphonates (Etidronate is a member of this group) act on the MST
kinases directly, both of which result in the induction of cellular apoptosis
from references 36>66.67,68
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Adapted

Figure 19: Bisphosphonate Action
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Table 11; Surgery and sacrifice data for all rabbits in this study are complied in this
table. The weights at surgery and sacrifice are listed, the operative weight was not
significantly different between groups, while the weight at sacrifice was increased in the
saline and indomethacin groups. The average graft length and cross-clamp time did not
vary significantly between groups.
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Table 11: Surgery and Graft Data
Rabbit
#

Surgery
Date

Saline Treated
HSS42
03/12/03
H8541
03/12/03
H8S38
03/14/03
H8536
03/21/03
H8540
03/23/03
Mean ± Std Dev

Date
Opened

Sacrifice
Date

Weight @
Sacrifice

27.5
25
27
31.5
25
27.2±2.7

2B0110-03002
2B0110-03015
2B0110-03013
2B0110-03022
2B0110-03019

03/05/03
03/12/03
03/14/03
03/20/03
03/21/03

05/14/03
05/14/03
05/16/03
05/23/03
05/26/03

4.88kg
4.66
4.54
4.88
4.5
4.69±0.2

4.1
4
4
3.9
4
4±0.1

23.2
26.5
24.75
21.4
24
23.9±1.9

2B0110-03022
2B0110-03013
2B0110-03014
2B0110-03022
2B0110-03021

03/05/03
03/14/03
03/21/03
03/20/03
04/08/03

05/27/03
06/03/03
06/06/03
06/09/03
06/16/03

4.89kg
3.97
4.5
4.3
4.65
4.46±0.4

3.9
3.9
4
4
3.9
3.95±0.1

24
24.2
24
21
29
24.5±3.3

2B0110-03022
2B0110-03002
2B0110-03015
2B0110-03013
280110-03021

05/05/03
03/05/03
03/12/03
03/14/03
04/08/03

05/30/03
06/30/03
07/01/03
07/02/03
07/8/03

3.6kg
3.4
3.4
3.5
3.5
3.48±0.1

Graft
Length

3.6kg
3.4
3.75
3.86
3.6
3.64±0.2

4.2cm
4
4
4
4
4.04±0.2

3.29
3.86
3.97
3.97
3.79±0.3
3.75kq
3.86
3.86
3.75
4.4
3.97±0.3

Indomethacin Treated
03/25/03
3.86kq
H8535
H8794
04/01/03
H8790
04/04/03
H8797
04/07/03
H8792
04/14/03
Mean ± Std Dev
Etidronate Treated
H9085"
05/05/03
H9086
04/28/03
H9087
04/29/03
H9084
04/30/03
H9081
05/06/03
Mean ± Std Dev
^Sacrificed at 25 days

Graft#

Weight @
Surgery

X-Ciamp
(min)
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Table 12; The sacrifice dates are listed for all rabbits, as is the duration o f the graft
implantation. All rabbits were sacrificed at 63 days except for H9085 which was
sacrificed at 25 days.
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Table 12: Sacrifice Dates

Rabbit #
Cause of Death
Saline Control
H8542
Sacrificed
H8541
Sacrificed
H8538
Sacrificed
H8536
Sacrificed
H8540
Sacrificed
indomethacin Treatment
H8535
Sacrificed
H8794
Sacrificed
H8790
Sacrificed
H8797
Sacrificed
H8792
Sacrificed
Etidronate Treatment
H9085
Euthanized
H9086
Sacrificed
H9087
Sacrificed
H9084
Sacrificed
H9081
Sacrificed

Duration
63
63
63
63
63

days
days
days
days
days

63
63
63
63
63

days
days
days
days
days

25
63
63
63
63

days*
days
days
days
days
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